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The retinoid X receptor (RXR) is a ligand-activated transcription factor and a member of the 
nuclear receptor (NR) superfamily. RXR consists of three major isotypes, i.e., RXRa, RXRb 
and RXRg, and several isoforms. This diversity makes RXR to be directly and indirectly 
involved in a vast array of cellular signaling pathways, mediating cellular responses as both a 
homo- and heterodimeric transcription factor. Depending on RXR isotype/isoform, ligand, and 
associated NR partner proteins, RXR regulates physiological processes such as embryogenesis, 
organogenesis, lipid metabolism and homeostasis. Along with endogenous ligands (9-cis-
retinoic acid), some environmental pollutants have been observed to disrupt RXR signaling and 
gene regulation. Organic tin compounds (OTCs) are a subgroup of environmental pollutants 
that are particularly prominent and potent in marine environments, when compared to 
terrestrial, which previously have been observed to act in an endocrine disruptive manner 
through binding to RXR. The identification and characterization of RXR isoforms in 
ecologically and economically important marine species, such as Atlantic cod (Gadus morhua), 
along with the potential RXR-disruptive properties of environmental pollutants, including 
OTCs, have not yet been carried out. Thus, this study was performed to uncover and 
characterize the primary structures of the RXR isoforms encoded in the Atlantic cod genome 
(gmRXRs), analyze their tissue specific expression profiles, and assess the potential of 
endogenous (9-cis-RA) and exogenous (i.e., tributyltin, tripropyltin, triphenyltin and 
trimethyltin) ligands to induce the transcriptional activation of gmRXR proteins. Through 
genome mining and phylogenetic analysis, four RXR isoforms were identified in the Atlantic 
cod genome; gmRXRa, gmRXRb1, gmRXRb2 and gmRXRg. cDNA derived from juvenile 
Atlantic cod tissues was used to assess the tissue specific expression of the gmRXR isoforms. 
Based on the expression profiles, gmRXRb1 and gmRXRg were cloned from Atlantic cod liver 
and used in establishing luciferase reporter gene assays. gmRXRg was transactivated by both 
9-cis-RA and most of OTCs tested. In contrast, gmRXRb1 was not activated during by 9-cis-
RA or by OTC exposure. Based on expression- and ligand activation profiles, gmRXRg and 
gmRXRb1 are suggested to act as important regulatory NRs in Atlantic cod. However, our 
study suggests that gmRXRb1 act as an obligate non-permissive heterodimer, while gmRXRg 
retains functionality as both a homo- and heterodimer. Importantly, the observed potential of 
OTCs to transactivate the Atlantic cod RXRg, along with the proposed physiological 
importance of RXR in Atlantic cod, could further indicate that OTC exposure may cause 
adverse effects in this species and potentially in other marine cold-water teleosts. 
 1 
1 Introduction  
1.1 Perspective 
As a result of the continuous industrialization and globalization over the last two centuries, 
anthropogenic pollutants have been emerging at an alarming rate in areas previously perceived 
to be unscathed. Offshore oil drilling, refineries, municipal discharges, mining and commercial 
travel and shipping are to name a few of the major perpetrators of land, water and air pollution. 
Common for many pollutants are their ability to persist in the environment by resisting physical 
and chemical degradation, allowing accumulation in biota and long-time exposures of 
organisms. Marine ecosystems are especially vulnerable to these compounds as they are being 
exposed to both legacy pollutants as well as acting as a sink for runoffs associated with 
terrestrial agriculture, industrial- and consumer waste. The potential adverse effects caused by 
pollutant exposure are many, with compounds possessing endocrine disrupting properties 
especially highlighted. Even at low concentrations (µM and nM ranges) these compounds can 
interfere with synthesis, transportation, secretion, elimination and general function of hormones 
and the endocrine system (Lauretta et al., 2019). The adverse effects reported of such pollutants 
include disruption of reproduction, reduced growth, and altered behavior, which may negatively 
affect individuals or even whole ecosystems. Increasing our knowledge of the physicochemical 
properties and adverse effects of environmental pollutants may give rise to preventive and 
prohibiting actions, in hopes to minimize their destructive potential.  
 
1.2 Environmental pollutants  
The term environmental pollution commonly refers to the influx of harmful anthropogenic 
chemicals into an environment at rates higher than that of storage, dispersion or decomposition 
(Scott & Sloman, 2004). Depending on the pollutant itself and their interaction with the 
environment, these compounds can be found residing in air, water and soil (Ukaogo et al., 
2020). The physicochemical properties of these environmental pollutants may vary greatly, 
however, some properties seem to be recurring. Especially troublesome are their ability to 
persist in environments and organisms through degradational resilience and potential for 
bioaccumulation and biomagnification (Windsor et al., 2020). Bioaccumulation occurs when 
the rate of absorption exceeds the rate of elimination in an organism, usually resulting in storage 
and accumulation in fatty tissue due to their lipophilic nature (Yarsan & Yipel, 2013). 
Biomagnification is the increase in pollutant concentrations in organisms at higher trophic 
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levels, as predators higher in the food chain are exposed to increased levels of accumulated 
pollutants through prey (Yarsan & Yipel, 2013). This allows pollutants to be readily available 
to exert their toxicological effects potentially at high concentrations. Examples of groups of 
environmental pollutants include metals (e.g., Pb, As, Hg, Cd, Sn), polycyclic aromatic 
hydrocarbons (PAH), dioxins, polychlorinated biphenyls (PCBs), brominated diphenyl ethers 
(flame retardants), perfluorinated compounds, pesticides (e.g., organotin, organochlorine, 
organophosphate and neonicotinoid compounds), phthalates, and micro/nano-plastics (Griffith 
et al., 2015). 
 
Persistent organic pollutants (POPs) are an important and commonly highlighted fraction when 
discussing environmental pollutants. POPs are usually referring to highly toxic compounds able 
to cause both acute and adverse health effects even at low concentrations (Mortimer, 2013). 
Moreover, POPs are known to resist chemical and physical degradation and can bioaccumulate 
and biomagnify in lipid rich biota (Windsor et al., 2020). Another important property shared by 
many POPs, are their ability to volatilize from soil and water, entering the atmosphere where 
they are carried over great distances before re-depositing (Ashraf, 2017). This becomes a 
cyclical phenomenon and is proposed as the mechanism in which POPs end up in remote 
environments far from where they were released (K. C. Jones & de Voogt, 1999). Due to the 
ability of long transportation and the highly toxic potential of POPs, the Stockholm convention 
of 2001 proposed a priority list of twelve POPs called the “dirty dozen”. The goal was to reduce 
and/or eliminate their production and use. These POPs were recognized to cause adverse effects 
in humans and ecosystems, and included pesticides, industrial chemicals and by-products, such 
as aldrin, chlordane, dichlorodiphenyltrichloroethane (DDT), dieldrin, endrin, heptachlor, 
hexachlorbenzene (HCB), mirex, toxaphene, polychlorinated biphenyls (PCB), polychlorinated 
dibenzo-p-dioxins (PCDD) and polychlorinated dibenzofurans (PCDF) (Tokuç, 2013). 
Although only twelve compounds were initially added, groups like PCB contain 209 individual 
congeners. Later, nine POPs were added to the Stockholm convention (denoted as the “nasty 
nine”) including among others hexabromobiphenyl, chlordecone, lindane and 
perfluorooctanesulfonic acid (PFOS) (Palanisami & Naidu, 2010). However, although the 
production of many chemicals has significantly decreased, the prolonged half-life of POPs in 




1.3 Organic tin compounds (OTCs)  
Organic tin compounds (OTCs) constitute the most widely used organometallic chemicals, and 
are characterized by their tin (Sn) atom bound to organic substituents (e.g., propyl, phenyl, 
methyl, butyl) (Hoch, 2001). OTCs are found in industrial commodities including pesticides 
such as fungicides, biocides, molluscicides, anti-fouling agents and polyvinyl chloride (PVC) 
stabilizers (Haschek et al., 2010). Some OTCs can also be found in surface disinfectants, curing 
agents, ballistic additives and even rocket fuel (Okoro et al., 2014). Of the 800 or so known 
OTCs, all but methyltin stem from an anthropogenic origin. From its first commercial use as an 
PVC stabilizer in the 1940s, OTC production increased by a tenfold from 1950 (~5000 tons) to 
1992 (~50 000 tons) (Hoch, 2001). Although many OTCs are banned from commercial use 
today, the large-scale use of these compounds throughout the 20th century and early 2000s has 
given rise to ubiquitous contamination of marine environments (Ho et al., 2016). Although not 
yet classified as a POP, many of the most prominent members of the OTC family share the 
functional properties with their POP counterparts.  
 
Historically, tributyltin (TBT) and triphenyltin (fentin) have been some of the most used OTCs. 
Along with tripropyltin (TPT), TBT and fentin are two of the most toxic OTCs with properties 
making them resistant to natural degradation (Haschek et al., 2010). These OTCs are 
presumably more toxic in marine environments compared to terrestrial, and due to the extensive 
use as antifouling biocides for ships, TBT and fentin are ubiquitously distributed in aquatic 
ecosystems (Doherty & Irwin, 2011). At the surface and in the water column, the half-life of 
these compounds ranges from 10-100 days, whereas TBT and fentin deposited in sediments 
allow for a drastic increase in half-life ranging from 1-4 years (Cruz et al., 2015). TBT and 
fentin, along with other OTCs, are also able to bioaccumulate and biomagnify in both 
vertebrates and invertebrates (Doherty & Irwin, 2011). TBT and fentin have been associated 
with endocrine disruption in marine and terrestrial organisms, especially prominent is the 
phenomenon of imposex found in gastropods. Organotin induced imposex have been observed 
in over 150 species of gastropods at low concentrations (ng/L), resulting in reproductive 
abnormalities (Pellizzato et al., 2004). These abnormalities involve a superimposition of male 
features in female organisms, e.g. a penis or vas deferens, which can lead to infertility and 
premature death able to affect entire populations (Pellizzato et al., 2004). Interestingly, recent 
studies indicate the involvement of a nuclear receptor (NR), i.e. the retinoid X receptor (RXR), 
in developing imposex through OTC-mediated disruption of RXR signaling (Huang et al., 
2020). Giulianelli et al., (2020) reported that expression of gastropod RXR was significantly 
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different between OTC exposed and non-OTC exposed gastropods, providing further evidence 
of OTC role in imposex development through inducing RXR disruption (Giulianelli et al., 
2020). Furthermore, RXR is reported to regulate aromatase activity through transcriptional 
regulation of CYP19 in Danio rerio. It is reported that OTC binding to D. rerio RXR disrupts 
RXR signaling causing disruption of CYP19 synthesis resulting in aromatase inhibition, 
causing masculinization of female D. rerio individuals (Cheshenko et al., 2008). In contrast, 
OTCs are observed to markedly enhance the rate of estradiol biosynthesis and increase 
aromatase activity in human carcinoma cells  (Nakanishi et al., 2005). Some papers state that 
an aromatase-like inhibition is also found during gastropod imposex development. However, 
as the CYP19 aromatase enzymes believed to be involved in vertebrate masculinization and 
decreased/increased aromatase activation, are not present in gastropods (Fodor et al., 2020). 
Thus, resent studies disregard the hypothesis of OTC induced aromatase-like inhibition in 
gastropod imposex, concluding that the RXR target genes during OTC-induced signaling 
disruption is yet to be elucidated (Fodor et al., 2020; He et al 2021). Nevertheless, the evidence 
of OTC-induced sexual differentiation through RXR disruption in marine organisms is strong, 
however, the processes and factors triggering changes in CYP19 activity, or other enzymes, is 
not clear. Continuing, prolonged exposure of OTCs is observed to result in cytotoxicity, 
hepatotoxicity and neurotoxicity through perturbation of calcium homeostasis and depression 
of aminopyrine demethylase in organisms ranging from bacteria to mammals (Hagger et al., 




Figure 1. Organic tin compounds. The chemical structure and names of five prominent OTCs found in marine 







1.4 Nuclear receptors 
Nuclear receptors (NRs) are an evolutionary related superfamily of mostly ligand-activated 
transcription factors. All NRs are structurally similar proteins and share five functional 
domains, including an N-terminal DNA binding domain (DBD), a hinge region, and a ligand 
binding domain (LBD) (Jin & Li, 2010). Although nuclear receptors share structural 
similarities, variations in the LBD and DBD allow NRs to regulate a vast amount of different 
cellular processes in order to preserve normal cellular physiology. These processes include 
development, reproduction, metabolism, cell proliferation, immune response, and enzymatic 
activity (Porter et al., 2019). Due to the diversity of NRs and their widespread cellular 
involvement, irregularities in their expression and function as a result of internal and external 
stressors have long been associated with a magnitude of diseases. The suspected involvement 
of NRs in cancer, cardiovascular diseases, and type II diabetes as a result of endocrine 
disrupting xenobiotics, has resulted in continuous research and development of NR targeted 
drugs (Sladek, 2003). Further, the ability of environmental pollutants to disrupt NR function is 
of great importance for our understanding of how continuous exposure to pollution might 
manifest as negative adverse health effects on single organisms, populations and even whole 
environments.   
 
In order to exert their roles as transcription factors, nuclear receptors bind mostly small 
lipophilic ligands (e.g., steroids, hormones, retinoids and phospholipids) and/or form dimeric 
partners (Porter et al., 2019). Unlike most intercellular signaling molecules, which act via 
surface receptors, NR ligands are able to cross the cell membrane and interact directly with the 
nuclear receptors within the cells (Miller & Lappin, 2021). Once bound to a NR, the ligand 
mediates conformational changes to the nuclear receptor into an active conformation. 
Depending on the NR and the structural alterations caused by the ligand-binding, the nuclear 
receptor will either bind (as homodimers, heterodimers or tetramers) or release themselves from 
specific response elements in DNA upstream of their target genes (Penvose et al., 2019). If the 
response to ligand binding causes release from DNA, or inhibition to bind to DNA, the ligand 
is said to have an antagonistic effect. Promotion of binding to DNA and mediating transcription 
of target genes as a result of ligand-binding is called agonism (Lagarde et al., 2016). As a result 
of their sequence similarity, as well as ligand- and DNA binding characteristics, NRs are 
commonly grouped into nine major subfamilies: NR0, NR1, NR2, NR3, NR4, NR5, NR6, NR7 
and NR8 (Weikum et al., 2018). Perhaps the most notable of these subfamilies, are NR1 and 
NR2. NR1 is the largest subfamily and contains several NRs regulated by a variety of 
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liphophilic ligands. The NRs of the NR1 subfamily include thyroid hormone receptor (TR), 
retinoic acid receptor (RAR), peroxiosome proliferator activated receptors (PPAR), and others 
(Fig 2). NR2 is the second largest subfamily, this subfamily is often highlighted due to the 
inclusion of RXR, which is known to form heterodimeric relations with many NR1 NRs 
(Penvose et al., 2019), and in turn directly and indirectly regulate signaling and function of 
these partner NRs.  
 
Figure 2. The NR superfamily. A schematic overview of the nine different NR subfamilies (NR0-NR8) and the 
individual NRs belonging to each subfamily.  
 
 
1.5 Retinoid X receptor 
1.5.1 Isoforms, dimeric interactions and functional roles 
The retinoid X receptor (RXR) is a subfamily II (NR2B) NR and unique in its ability to 
heterodimerize with a vast array of NRs in most metazoan life (Moraes et al., 2007). RXR 
consists of three distinct isotypes (a, b and g) each encoded by separate genes located on 
different chromosomes. Due to genome duplication events, multiple isoforms of the three 
isotypes exist (a1, a2, b1, b2, g1, g2, d and e) (Mukha et al., 2021). The many isotypes and 
isoforms of RXR make this NR able to associate, heterodimerize and activate a plethora of other 
NRs, including peroxisome proliferator-activated receptor (PPAR), retinoic acid receptors 
(RARs), pregnane X receptor (PXR), liver X receptor (LXR) and farnesoid X receptor (FXR) 
(Szanto et al., 2004). In these functional dimers, RXR acts both in a non-permissive and a 
permissive manner (Aranda & Pascual, 2001). As a non-permissive partner, RXR form 
heterodimers with NRs like vitamin D receptor (VDR) and RAR. Here, RXR ligands alone are 
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incapable of initiating transcriptional activation, and ligand binding to RXR is precluded. Once 
the partner NR has activated the heterodimer, ligand binding to RXR can occur to enhance the 
transcriptional response in an additive or synergistic fashion (Evans & Mangelsdorf, 2014). In 
contrast, RXR:PPAR and RXR:FXR are permissive partners where ligand binding to one of the 
two NRs is sufficient to transcriptionally activate the heterodimeric-complex. Synergistic 
activation is possible when both RXR and partner NR is bound by a ligand (Castillo et al., 
2004). 
 
Figure 3. RXR as a non-permissive and permissive heterodimer.  Figure shows RXR as a non-permissive 
heterodimer (1) and permissive heterodimer (2) bound to DNA response elements (blue). (1) Non-permissive 
heterodimer of RXR and RAR and (2) permissive heterodimer between RXR and PPAR. “X” indicates no 
transcriptional activation, “+” indicates transcriptional activation of target gene, and “+++” indicates synergistical 
transcriptional activation of target gene.  
 
 
As a homodimer, RXR isoforms have been observed to activate transcription of non-native 
target genes such as genes normally targeted by PPAR (IJpenberg et al., 2004). Although RXR 
possess the ability to activate transcription as a homodimer has been documented, the physical 
mechanisms and the distinct pathways, including target genes, remain poorly understood. RXRs 
ability to heterodimerize, and thus activate numerous partner NRs, alongside its ability to 
function in an homodimeric fashion makes it directly and indirectly involved in numerous 
crucial cellular signaling pathways (Evans & Mangelsdorf, 2014). These pathways act as 
regulatory mechanisms in several processes, including lipid metabolism, cell differentiation, 
homeostasis, apoptosis and developmental processes such as organogenesis and embryogenesis 
(Dawson & Xia, 2012). However, RXRs ability to both homo- and heterodimerize and exert its 
role in signaling pathways, depends not solely on homo- and heterodimeric interactions but also 
the presence of a ligand along multiple co-factors. In fact, the absence of ligands and co-factors 
results in a homo-tetrameric configuration in which RXR remains unactive (Gampe et al., 
2000).  
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1.5.2 RXR protein structure 
Small differences in the primary structures of RXRa, RXRb and RXRg manifests as their ability 
to associate with different ligands and dimeric partners and thus be involved in different cellular 
pathways and processes. As with most NRs, all RXR isoforms exhibit a modular structure with 
regions of distinct functional domains. These domains are the non-conserved N-terminal 
domain (A/B), a highly conserved DBD (C), a non-conserved hinge region (D), a moderately 
conserved LBD (E) and a highly varied C-terminal (F) (Dawson & Xia, 2012). The specific 
functions of the different domains are outlined below.  
 
Figure 4. Illustration of the five functional domains of RXR, including activation function 1 and 2 (AF-1 and AF-
2). A/B= N-terminal domain, C= DNA binding domain, D= hinge region, E= ligand binding domain and F= C-
terminal.  
 
- The N-terminal domain, or activation function 1 (AF1), acts in a promoter-specific 
manner through ligand independent interactions with several co-regulators. This site 
is further associated with post-translational modifications to repress or increase the 
rate of transcription (Dowhan & Muscat, 1996).  
- The DBD is the domain that is most conserved in all the isoforms. The DBD contains 
two subdomains consisting of an amphipathic helix and a peptide loop. The 
amphipathic helix in the first domain interacts with the major groove through a 
DNA-reading helix, making base specific interactions. The second subdomain 
interact with the DNA backbone through non-specific interactions. The peptide loop 
in the second subdomain is also responsible for dimerization as it contains the distal 
box (D-box). Together the two subdomains create the DNA-binding zinc finger 
motif that recognizes and binds specific DNA-sequences (response elements) at a 
high affinity in a monomeric or dimeric fashion (Dawson & Xia, 2012).  
- The hinge region functions as a flexible link between the DBD and the LBD. This 
region is the generally shortest in length and most commonly the least conserved 
part, but it may contain a nuclear localization signal and is a region where post 
translational modification may occur (Weikum et al., 2018). 
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-  The LBD is moderately conserved, however, changes to this amino acid sequence 
manifests as the major differences in practical functionality between the receptor 
isoforms. The LBD is a highly complex multifunctional allosteric signaling domain, 
where binding of both ligand and co-factors, as well as hetero- and homodimeric 
mediation and interaction with other proteins, such as heatshock proteins, occurs 
(Egea et al., 2000). The binding of ligand and/or co-factors results in conformational 
changes of the LBD, increasing or inhibiting RXRs rate of transcription as well as 
formation of partner protein complexes. The LBD consists of 12 alpha-helices (H1-
H12), and in between H5 and H6 a small single beta-turn. The structure of the LBD 
is commonly referred to as an antiparallel helical sandwich, which creates a 
hydrophobic cavity at the base of the LBD termed the ligand binding pocket. As the 
name entails, this is where ligands are accommodated and bound to the LBD. The 
activation function 2 (AF2) is responsible for dynamic changes upon ligand binding, 
as ligand binding facilitate oriental change forcing AF2 to interact with new co-
regulator proteins (Dawson & Xia, 2012).  
- The C-terminal domain contains the highest amounts of variability in amino acid 
sequence. Due to the high sequence variability, little is known about its functional 
role in RXR and other NRs in general.  
 
1.5.3 Transcriptional activation of RXR 
Upon ligand binding RXR undergoes major conformational changes in the helices and loops of 
the LBD. The LBD of RXR exists in two forms: “apo” or “holo” (Egea et al., 2000). The apo 
form is the configuration of the LBD where all helices are present due to the absence of a bound 
ligand. When bound by a ligand, the LBD retains a holo form where a structural reconfiguration 
occurs through unwinding of H2, permitting a tilt of H3 where a surface structure between H3, 
H4 and H12 forms. This surface structure unmasks recognition sites called NR box motifs 
allowing co-factor binding, as well as altering the homo- and heterodimeric interfaces (Dawson 
& Xia, 2012). The structural reconfiguration of the LBD can therefore potentially result in three 
distinct alterations to the receptor function. First, changed state of multimerization due to 
alterations to the self-associative activity; second, altered degree of co-activator or co-repressor 
binding by conformational changes; finally, altered interface structure resulting in 
increased/decreased homo- or heterodimeric stability (Ahuja et al., 2003). 
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Figure 5. Apo- and holo-configuration of RXRa LBD with helices (H1-H12). (1) Unligated Human RXRa-
LBD retaining its un-active apo-configuration. (2) Human RXRa-LBD bound by agonist ligand allowing an holo-
configuration and subsequent transcriptional activation. Crystal structures obtained from on Protein Data Bank 
(PDB), crystal structure 1LBD (apo) and 1MVC (holo), with modifications by (Dawson & Xia, 2012). 
 
 
1.5.4 RXR endogenous ligands 
The matter of RXRs natural endogenous ligand(s) is perhaps one of the most controversial and 
enigmatic aspects of RXR research. Vitamin A studies in the late 1980s and early 1990s 
observed RXR as a novel retinoid responsive transcription factor (Levin et al., 1992). 
Subsequent research proposed 9-cis-retinoic acid (9-cis-RA) as a likely natural ligand for RXR 
due to its high affinity binding. Both organic and synthetic 9-cis-RA are vitamin A derivates 
containing a carboxylate group and a long aliphatic chain (Tsuji et al., 2015). This retinoid is 
involved in numerous physiological pathways as a non-steroidal hormone, enforcing their 
pleiotropic effects through signal transduction of RXR and retinoic acid receptor (RAR) (Kane, 
2012). Unlike RAR, which bind 9-cis-RA among other retinoic acids such as all-trans-RA 
(ATRA), RXR is known to exclusively bind 9-cis-RA with high affinity (Tate et al., 1994). In 
linages such as vertebrates, annelids and mollusks, this canonical high affinity 9-cis-RA binding 
to RXR has been confirmed (Fonseca et al., 2020). Interestingly, in cephalochordates this 
binding is maintained albeit at a much lower affinity, whilst in Daphnia magna, 9-cis-RA 
binding does not always yield transcriptional activation (Fonseca et al., 2020). The difficulties 
in detecting and validating endogenous 9-cis-RA in embryos and developing tissues are what 
mainly fuels the debate regarding its status as a bona fide endogenous RXR ligand (Wolf, 2006). 
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Thus, in recent times, other compounds have been proposed as potential endogenous ligands. 
Some of the common examples are docosahexaenoic acid, lithocholic acid, and phytanic acid, 
all capable of binding to- and activating RXR at high affinity and efficiency (Szanto et al., 
2004). However, since high affinity binding of 9-cis-RA to RXR is found conserved throughout 










Figure 6. Endogenous ligands capable of inducing RXR-mediated transcription through receptor binding.  
 
1.5.5 Organic tin compounds as exogenous RXR ligands 
With the discovery of OTCs innate ability to deregulate and disrupt endocrine pathways at low 
concentrations, OTCs such as TBT was later observed to activate RXR:PPAR heterodimers  (le 
Maire et al., 2009; Hagger et al., 2005). The result of the heterodimeric activation was 
promotion of adipocyte differentiation and disruption of aromatase transcription in human 
carcinoma cell lines (i.e. JAr, JEG-3 and BeWo) (Nakanishi et al., 2005). Thus, RXR and PPAR 
became dominant nuclear receptors in uncovering the mechanism of action of OTCs as an 
exogenous ligand. Interestingly, OTCs do not resemble 9-cis-RA or other retinoids chemically 
or physically, as OTCs lack a functional polar group (Hiromori et al., 2015). Although RXR 
and PPAR form a permissive heterodimer, le Maire et al., (2009) suggested that the lack of 
appropriate cysteine groups in PPAR-LBD deterred OTCs from binding. It was further 
suggested that the lack of a polar group in OTCs caused the compound to interact with different 
amino acids in the LBD compared to 9-cis-RA, in fact, OTCs seemingly interact with only a 
small subset of the LBD amino acid residues in RXR. Particularly important for RXR-OTC 
interactions, is a highly conserved cysteine-residue located on the C-terminal. Upon OTC 
binding, the ligands will form weak van der Waals contacts between themselves and the LBD. 
Here, OTCs alkyl groups further positions the innate tin (Sn) atom, in the core of OTCs, 
according to the C-residue. From here, the Sn atom is bound covalently to the C-residue of the 
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RXR-LBD, with the C-residue acting as anchoring point and stabilator during binding. Active 
OTCs, such as TBT, TPT, FC and FH, are shown to mediate RXR disruption through such 
interactions with the C-residue. In contrast, OTCs with fewer and/or too short/long alkyl groups 
(i.e., triethyltin or trioctyltin) results in too few contact points to align the Sn-atom with the C-
residue, leading to RXR´s inability to accommodate OTC binding (le Maire et al., 2009).  
 
1.6 Atlantic cod (Gadus morhua)  
Atlantic cod is a common teleost widely distributed across the North Atlantic Ocean, spanning 
form the north-eastern coast of North America to the Barents Sea in Northern Europe. Atlantic 
cod is often divided into coastal- and oceanic cod based on their migratory behavior and 
genomic divergence (Berg et al., 2016). The costal cod populations are known to remain within 
relatively small geographic locations along shallow coastal waters (0-500 meters) and fjords. 
They are commonly found in the benthopelagic zone but do reside closer to the surface (pelagic) 
during spawning. In contrast, the oceanic cod is pelagic and known to migrate over large 
distances. The oceanic cod population of the North-east Arctic migrates from the Barents Sea 
along the Norwegian coast down to Møre during spawning season (Wennevik et al., 2008).  
 
 
Figure 7. Atlantic cod distribution. Illustration of the global distribution of Atlantic cod, with populations 
spanning the Atlantic Ocean from the North-east of North America to the Baltic Sea. Illustration based on 





For Norway, export of commercially captured Atlantic cod has been, and continues to be, 
important for economic growth. In 2019, the Norwegian export of fresh, dried and salted 
Atlantic cod was estimated to provide over 7 billion NOK in revenue. However, this was the 
result of 330 thousand tons of Atlantic cod being captured during the same year (SSB, 2020). 
In the late 90s to the early 2000s, several Atlantic cod populations collapsed due to overfishing 
in areas around Canada and the North Sea (Stokstad, 2021). Today the repercussions are still 
present as many of these populations are yet to recover. However, capture quotas have allowed 
many of these recovering populations to slowly experience a steady incline (Garrod, 2011). 
Although there is a general positive trend in Atlantic cod populations, it is still a threatened 
species where many theorize that additional stress from environmental pollutants and climate 
change will disrupt spawning season and inhibit the populations to fully recover (Link et al., 
2009).  
 
Both coastal- and oceanic cod are pivotal in maintaining a stable ecosystem, as they act as the 
major piscivore predators in their ecosystems, along being important prey for other species such 
as minke whales (Balaenoptera acutorostrata) and harp seals (Pagophilus groenlandicus) 
(Haug et al., 2017). Due to the ecological and economical importance of Atlantic cod, it has 
since the 1980s been used in environmental monitoring studies as a bioindicator species 
(Søfteland et al., 2010). A focal point of these studies is to better understand the effects 
environmental pollutants have on Atlantic cod and marine teleost´s. The publishing of the whole 
Atlantic cod genome by Star et al. 2011, facilitated the opportunity to obtain quantitative 
response data to pollutant exposure in Atlantic cod on a genomic scale. Such data may provide 
an important insight to how Atlantic cod, and marine wildlife in general, responds to the 









1.6.1 RXR in Atlantic cod 
Although RXR isoforms from model organisms such as D. rerio are relatively well described, 
little is known about the structural or functional characteristics of RXR in other teleost species, 
such as Atlantic cod. However, in contrast to most mammalian species that possess only one 
isoform of RXRa, RXRb and RXRg, teleost RXR constitutes numerous RXR isoforms, 
including two RXRa, two RXRb and two RXRg variants, along with an RXRe and an RXRd 
that are only observed in some teleost fish. The vast array of different RXR isoforms present in 
teleost species are believed to be the result of teleost specific whole genome (TS-WGD) events, 
or tandem duplication events of RXR encoding genes. This has allowed teleost specific RXR 
isoforms to arise with new functional properties compared to mammalian orthologs, through 
neo- and subfunctionalization events. Eide et al. published in 2018 a genome mining study 
where all members of the NR superfamily were identified in Atlantic cod genome, 
demonstrating the presence of four RXR isoforms. Interestingly, this paper showcased the loss 
of PXR in Atlantic cod, and most other species in the Gadiformes order. The PXR-RXR 
heterodimer is believed to play an important role in mediating and controlling the xenobiotic 
response in vertebrates through binding of several NR response elements, including the 
CYP3A4 promoter (Delfosse et al., 2021)(Aranda & Pascual, 2001). Thus, the absence of PXR 
raise several interesting questions from an evolutionary and toxicological perspective, 
regarding the xenobiotic response mechanisms and the potential alteration of RXR function in 
Atlantic cod. Particularly interesting is the mechanisms in which OTC may affect RXR 
function. As described in 1.3, RXR in D. rerio is strongly linked to OTC induced 
masculinization through aromatase inhibition of CYP19 enzymes. OTCs in other teleost species 
such as Salmo salar and Acanthopagrus schleigelii, have further been observed to mediate RXR 
disruption resulting in fluctuating gonadal and neural aromatase activity (Cheshenko et al., 
2008). Thus, it is suggested that OTCs induces RXR disruption in several teleost species. 
However, as of today, the primary structure, ligand activation, tissue specific expression, and 
xenobiotic activation of gmRXR are yet to be characterized and is vital to the understanding of 







1.7 Aim of the study  
RXR has not previously been characterized on a molecular level in Atlantic cod. The present 
study therefore aims to uncover and characterize the primary structures and phylogeny of the 
gmRXR isoforms and analyze their tissue specific expression profiles. The tissue specific 
expression profile will provide insight into possible gmRXR function and based on liver 
expression profiles, the isoforms most prominently expressed here will further be cloned and 
integrated into a luciferase-based reporter gene assay. Through the luciferase reporter gene 
assay, the efficacies and potencies of 9-cis-RA and OTCs (TBT, TPT, FC, FH and TMTC) in 
transactivating gmRXRs will be assessed in vitro. The natural endogenous ligand for RXR is 
still debated, however, 9-cis-RA is widely regarded as a viable candidate. Therefore, the ability 
of 9-cis-RA to induce transactivation of RXR in Atlantic cod is assessed to investigate its 
proposed role as an endogenous RXR ligand. Further, OTCs are a group of highly toxic 
pollutants, reported to be potent agonists for RXR in other species. However, the effects of 
OTCs on RXR in marine cold-water teleosts are scarce, and no data exists on OTC-mediated 
transactivation in Atlantic cod. Although the abundance of OTCs in environments is declining, 
the hormone disruptive properties of OTCs through RXR disruption are reported to be 
significantly more potent in marine environments compared to terrestrial environments. 
Therefore, this study aims to assess the possibility for these compounds to induce activation of 
Atlantic cod RXR at low concentrations (nM-µM) and investigate the potential adverse effects 
OTC induced RXR activation may cause. The four major objectives for this study are listed 
below.  
 
I. Perform bioinformatical analyses of DNA- and protein sequences of Atlantic cod RXR 
isoforms, including phylogeny and annotation of important functional domains and 
sequence features such as the DBD, LBD and ligand binding residues.  
II. Analyze the tissue specific expression profiles of RXR in Atlantic cod using a 
comprehensive library of tissue samples. 
III. Establish an in vitro reporter gene assay for assessing ligand-binding and transcriptional 
activation of RXR isoforms.  
IV. Examine possible transcriptional activation of RXR isoforms induced by the 




2.1 Chemicals and reagents  
Table 1. List of chemicals and reagents used  
Name Chemical formula  Supplier  
10X loading buffer - TaKaRA 
2-Log DNA ladder - New England  
2-b-Mercaptoethanol HSCH2CH2OH Aldrich  












Acetic acid CH₃COOH Sigma-Aldrich  
Acrylamide-Bis  Bio-Rad 
Adenosin 5´trifosfat disodium salt 
hydrate 
C3H5NO Sigma-Aldrich  
Agar-agar - Merck  
Agarose - Sigma-Aldrich  
Ammonium persulfate (NH4)2S2O8 Sigma-Aldrich  
Ampicillin sodium salt C16H18N3NaO4S Sigma-Aldrich  
Betain C5H11NO2 Sigma-Aldrich  
Boric acid H3BO3 Merck  
Bovine serum albumin - Sigma-Aldrich  
Co-enzyme A - Thermo Fisher  
CHAPS C₃₂H₅₈N₂O₇S Thermo Fisher 
Dimethyl sulfoxide C2H6OS Sigma-Aldrich 
Disodiumhydrogenphosphate Na2HPO4 Sigma-Aldrich 
DL-Dithiothreitol HSCH2CH(OH)CH(OH)CH2SH Sigma-Aldrich 
D-luciferin sodium salt C11H8N2O3S2 Biosynth  
Dulbecco´s modified Eagle’s 
medium (phenol red) 
- Sigma-Aldrich 
Dulbecco´s modified Eagle’s 
medium (w/o phenol red) 
- Sigma-Aldrich 
Erythrosin-B C20H8I4O5 Sigma-Aldrich 
Ethanol C2H5OH Sigma-Aldrich 




Ethylenediaminetetraacetic acid C10H16N2O Sigma-Aldrich 
Fetal bovine serum  - Sigma-Aldrich 
Galactose  - Sigma-Aldrich 
Gel Red  - Biotium 
Glycerol  C3H8O3 Sigma-Aldrich 
Isopropanol  C3H8O Kemetyl 
L-glutamine  C5H10N2O3 Sigma-Aldrich 
L-a-Phosphatidylchlorine  C44H88NO8P Sigma-Aldrich 
Magnesium carbonate hydroxide 
pentahydrate 
(MgCO3)4 • Mg(OH)2 • 5H2O Sigma-Aldrich 
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Magnesium chloride hexahydrate  Mg(CL2) • 6H2O Sigma-Aldrich 
Magnesium sulfate heptahydrate  H14MgO11S Sigma-Aldrich 
Methanol  CH3OH Sigma-Aldrich 
Monosodium phosphate NaH2PO4 Sigma-Aldrich 
OPTI-MEM - Gibco 
Polysorbate 20 C58H114O26 Thermo Fisher 
Rezasurin sodium salt  C12H6NNaO4 Sigma-Aldrich 
Penicillin-Streptomycin - Sigma-Aldrich  
Phosphate-buffered saline Cl2H3K2Na3O8P2 Sigma-Aldrich 
Phenylmethylsulfonyl fluoride  C7H7FO2S Sigma-Aldrich 
Potassium chloride  KCl Sigma-Aldrich 
Sodium chloride  NaCl Merck  
Sodium dodecyl sulfate NaC12H25SO4 Merck  
Sodium pyruvate   C3H3NaO3 Sigma-Aldrich 
Trans IT-LT1 - Mirus Bio LLC 
Tricine  C6H13NO5 Sigma-Aldrich 
Tris-hydrochloric acid HCL Sigma-Aldrich 
Triton - Sigma-Aldrich 
Trypsine-EDTA  - Sigma-Aldrich 
Yeast extract   - Sigma-Aldrich 
 
2.2 Primers (Oligonucleotides) 
Table 2. All forward (fwd) and reverse (rev) primers used  
ID Name  Sequence 5´à3´ 
MT1984 RXRg fwd (qPCR) CAGAGATGTACACGGACAGCA 
MT1985 RXRg rev (qPCR) TCTAGGGGCAGCTCAGAGAA 
MT2002 RXRb1 fwd (qPCR) AGGTCTATGCATCACTGGAAGC 
MT2003 RXRb1 rev (qPCR) CAGATGCTCCAAGCACTTCA 
MT2022 RXRb2 fwd (qPCR) TTCCCTGGAGTCCTACTGCAAGC 
MT2023 RXRb2 rev (qPCR) TCCAGGCACTTCAGACCAAT 
MT1990 RXRa fwd (qPCR) CAACAAGGACTGCATCATCG 
MT1991 RXRa rev (qPCR) GAACGGCTGCGTGTAACAACA 
MT74  b-Act fwd GAGAAGATCTGGCATCACACCTTC 
MT75 b-Act rev GGTCTCGTGGATACCGCAAGATTC 
MT41 T3 fwd ATTAACCCTCACTAAAGGGA 
MT43 T7 rev TAATACGACTCACTATAGGG 
MT2024 RXRb1 fwd ggaaccGAATTCAAGGCTCTTGCGGTGCAGGA 
MT2025 RXRb1 rev cgagtcGCTAGCCTAAGATAACTGGTGGGGCGCTTCAAG 
MT2034 RXRg fwd gcagcaGAATTCAAGAGAGAAGCGGTGCAGGA 
MT2035 RXRg rev ttgccgGCTAGCTCATGTGATCTGGTGGGGAGCC 
MT1077 PCMX fwd TGCCGTCACAGATAGATTGG 
MT1279 PCMX rev AATCTCTGTAGGTAGTTTGTCCA 
MT1200 Arp fwd TGATCCTCCACGACGATGAG 








2.3 Enzymes  
Table 3. Overview of different enzymes used  
Name  Supplier  
AmpliTaq Gold DNA polymerase Thermo Fisher Scientifics  
Big dye terminator v3.1 Applied Biosystems  
DreamTaq green DNA-polymerase  Life Technologies  
EcoRI- Restriction enzyme  Takara  
NheI- Restriction enzyme Takara 
Phusion Hot Start II DNA polymerase Thermo Fisher Scientifics   
RNase 
RNaseOUT 
New England Biolabs  
Invitrogen  
Superscript III reverse transcriptase Invitrogen 
Shrimp alkaline phosphatase (SAP) Affymetric  
 
2.4 Plasmids  
Table 4. List of plasmids used 
Name  Use 
pCMX-GAL4-DBD Construction of pCMX-GAL4-RXRb1/g 
pCMX-GAL4-RXRb1 
pCMX-GAL4-RXRg 
Luciferase reporter gene assay 
Luciferase reporter gene assay 
pSC-B Blunt cloning vector  
pSC-B-RXRb1 Construction of pCMX-GAL4-RXRb1/g 
pSC-B-RXRg Construction of pCMX-GAL4-RXRb1/g 
mh(100)x4tk luc Luciferase reporter gene assay 
pCMV-b-Gal Luciferase reporter gene assay 
 
 
2.5 Eukaryotic and prokaryotic cell lines  
Table 5. Different cell lines used in thesis and their domain 
Name  Domain Supplier 
COS-7   Eukaryote (Gluzman, 1981) 
StrataClone Solo Pack Competent Cells  Prokaryote Agilent  
StrataClone “Mix&Go” Competent Cells  Prokaryote  Agilent  
 
2.6 Growth medium  
Table 6. Lysogeny Broth (LB) growth medium  
Component LB-agar LB-medium 
Tryptone  10 g/L 10 g/L 
NaCl 10 g/L 10 g/L 
Yeast extract 5 g/L 5 g/L 
Agar-agar 15 g/L - 
Ampicillin 100 mg/L 100 mg/L 
ddH2O - - 
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Table 7. Freezing medium and cultivation medium for COS-7-cell line  
Component  Concentration  
Dulbecco’s modified Eagle´s medium  1 X 
Fetal bovine serum  10% 
L-glutamine  4 mM 
Sodium pyruvate  1 mM 
Penicillin-Streptomycin  1 U/mL 
DMSO 5% 
 
2.7 Buffers and solutions  
2.7.1 Agarose gel  







2.7.2 Western blot assay  
Table 10. Components and volumes for running and stacking gel for one 12% SDS-page  
Component  12% Running Gel  12% Stacking gel  
ddH2O 2.48 mL 2.27 mL 
30% Acrylamide-Bis 3.0 mL 0.65 mL 
1.5M Tris pH8.8 1.9 mL - 
0.5M Tris pH6.8 - 1.0 mL 
20% SDS 37.5µL 20.0 µL 
10% APS 75µL 40.0 µL 
TEMED 3µL 4 µL 
 
Table 11. 5X sample buffer   Table 12. Lysis buffer for protein preparation 
  
 






Component  Concentration  
TBE-buffer 0.5 X 
Agarose  0.7-2% 
GelRed  0.0002% 
Component Concentration 
Tris  0.45 M 
Boric acid  0.45 M 
EDTA 0.01 M 
ddH2O - 
Component Concentration  
Tris HCl pH6.8 250 mM 
SDS 10% 
Glycerol  30% 
2-b-mercaptoethanol 5% 
Bromophenolblue  0.02% 
Component  Concentration 
5X Sample buffer 2X 
10X PBS pH 7.4 1X 
Protease inhibitor 1X 
ddH2O - 
Component  Concentration 
Tris base  25 mM 
Glycine  192 mM 
SDS 0.1% 
Component  Concentration 
Tris base  24 g 
NaCl 88 g 
MQH2O 900 ml 
32-N-HCL Adjust pH 
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2.7.3 Luciferase assay 
Table 19. 1X Cell lysis buffer            Table 20. Cell lysis reagent solution 
 
Table 21. 4X Luciferase base buffer (4X pH 7.8)    Table 22. Luciferase reaction solution 
 





2.7.4 Cell viability and cytotoxicity assay 
Table 25. L-15/ex A Table 26. L-15/ex B         Table 27. L-15/ex C 
Component  Conc. Component  Conc. Component  Conc. 
NaCL 80 g CaCL2 1.4 g Na2HPO4 1.9 g 
KCl 4 g ddH2O 100 mL KH2PO4 0.6 g 
MgSO4• 7H2O 2 g - - ddH2O 300 mL 
MgCl2• 6H2O 2 g - - - - 
ddH2O 600 mL - - - - 
 
Component Concentration 
10X TBS 0.5 X 
Tween 20 0.05% 
MQH2O - 
Component Concentration 
Tris base  30.3 g 
Glycine  14.4 g 
MQH2O - 
Component Concentration 
Powder milk 3.5 g 
TBS-tween 50 mL 
Component Concentration 
10X TG buffer 1X 
Methanol 2X 
ddH2O - 
Component  Concentration  





Component  Concentration  
Cell lysis buffer 1X 
EGTA 4 mM 
MgCl2 8 mM 
PMSF 0.4 mM 
DTT 1 mM 
Component  Concentration Component  Concentration 
Tricine  80 mM Luciferase buffer  1X 
(MgCO3)4 • Mg(OH)2 • 5H2O 4.28 mM ATP 0.5 mM 
Na2EDTA 0.4 mM DTT 5 mM 
MgCl2 10.68 mM Coenzyme A 0.2 mM 
- - D-luciferin  0.5 mM 
Component  Concentration 
Na2HPO4 60 mM 
NaH2PO4 40 mM 
KCl 10 mM 
MgSO4• 7H2O 1 mM 
Component  Concentration  
b-gal buffer 1X 
b-mercaptoethanol 4 mM 
ONPG 8 mM 
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Table 28. Cell viability solution  
Component  Concentration  
L-15/ex A 34 mL 
L-15/ex B 6 mL 
L-15/ex C 17 mL 
Galactose  0.8 mg/mL 
Pyruvate 0.5 mg/mL 
ddH2O 500 mL 
Resazurin  0.03 mg/mL 
CFDA-AM 0.00 1mg/mL 
 
 
2.8 Antibodies  
Table 29. Primary and secondary antibodies used in western blot assay 
Name  Supplier  
Anti-GAL4-DBD mouse monoclonal  Santa Cruz 
Horseradish peroxidase linked antibody sheep Anti-mouse IgG, polyclonal  GE Healthcare 
Anti b-actin monoclonal  Abcam 
 
 
2.9 Commercial kits  
Table 30. Overview of different commercial kits and their application   
Name  Supplier  Application   
NucleoBond Xtra Midi/Mini 
plasmid purification kit 
Macherey-Nagel  Plasmid purification 
NucleoSpin Plasmid EasyPure kit 
SuperSignal West Pico  
Thermo Scientific  Protein expression 
verification in COS-7 cells 
Chemiluminescent Substrate Thermo Scientific Protein expression 
verification in COS-7 cells 
NucleoSpin Gel and PCR clean-up Macherey-Nagel  Agarose gel extraction  
SuperScript Reverse Transcriptases Bio-Rad  cDNA synthesis  
BigDye Terminator v4.1 cylce 
sequencing kit  
Thermo Scientific  Sanger sequencing  
LightCycler 480 SyBR green I 
mastermix 
Roche qPCR amplification  
StrataClone Blunt PCR cloning kit Agilent  Blunt cloning into pSC-B 
T4 DNA-ligase kit  Takara Digest ligation of RXR and 
pCMX 








2.10 Ligands for luciferase assay 
Table 31. Ligands used for luciferase assay with 9-cis-RA and different organotins 
Name Supplier  CAS number 
9-cis-retinoic acid Sigma-Aldrich  5300-03-8 
Tributyltin chloride  Sigma-Aldrich  1461-22-9 
Tripropyltin chloride  Sigma-Aldrich 76-87-9 
Fentin chloride  Sigma-Aldrich  639-58-7 
Fentin hydroxide  Supleco  76-87-9 




2.11 Instruments  
Table 32. Overview of instruments and their application  
Name  Supplier Application  
Buerker hemocytometer Marienfield  Cell counting 
C1000™ Thermal Cycler  Bio-Rad qPCR amplification 
ChemiDoc™ XRS+system  Agarose gel picture  
Heraeus pico 21 Thermo 
Scientific 
Centrifugation  
DM IL inverted microscope  Leica Cell count and confluency 
determination 
EnSpire™ 2300 Multilabel Reader PerkinElmer  
GD100 Grant Heat-shocking in water bath  
Heraeus multifuge X3R Thermo 
scientific  
Centrifugation  
HS 501 Digital IKA®-
Werle 
Shaker  
MilliQ A10 advantage  Merck MQH2O dispenser 
MP220 Bergman pH-meter 
Nanodrop 1000  Thermo 
Scientific  
Concentration of RNA, DNA and 
cDNA 
PowerPac™ HC Bio-Rad Electric power to electrophoresis  
Multitron Standard shaking 
incubator 
Infors HT Cell cultivation incubation   
Ultraspec 10 cell density meter  Amersham 
Biosciences  
Culture density  
UV-transiluminator  UVP Agarose gel extraction  
Thermomixer compact Eppendorf Heat-block  
Panasonic mco-170aicuv-pe Lab-tec Incubation of CO7 with CO2 
Termaks incubator  Termaks  Incubator for transfected colonies  
CleanAir EuroFlow Class II 
biosafety cabinet   
Baker Sterilized workspace for handling 







2.12 Software   
Table 33. Overview of software and online tools and their application 
Name  Provider  Application   
Clustal Omega  EMBL-EBI Multiple sequence alignment 
Muscle  EMBL-EBI Multiple sequence alignment 
EMBOSS Needle  EMBL-EBI Pairwise sequence alignment 
MegaX v.10.2.6 Tamura et al. 2015 Phylogenetic analysis  
Ensembl  EMBL-EBI Genome browser  
Blast  NCBI Protein and DNA homology 
searches  
Genome Data Viewer  NCBI Chromosome location tool 
Protein Data Bank PBD Protein crystalline structures  
ExPASy SIB DNA to protein conversion  
Excel 2020 Microsoft  Processing data and statistics  
Jalview 2.11.1.4 Waterhouse et al. 2009 Visualization of sequence 
alignments  
GraphPad 9 Graphpad software  Figures and statistics   
Primer3 v.0.4.0 Howard Hughes Medical 
Institute  
Primer design  
SnapGene 5.3 Biotech Primer design and cloning 
simulations 
PowerPoint 2020 Microsoft  Figure preparation 
UniProt  EMBL-EBI and PIR Genome browser  
Wormweb 4.0 Nikhil Bhatla  Intron-exon illustrator  











3 Methods  
3.1 Experimental outline  
Throughout this thesis several bioinformatical- and molecular methods were applied. Figure 8 
represents an experimental outline containing the most significant steps.   
 
Figure 8. Experimental outline and important methods used. gmRXR-encoding gene sequences were revealed 
through genome mining. cDNA was prepared from various tissues and qPCR was used to obtain tissue-specific 
expression profiles of gmRXR isoforms in Atlantic cod. gmRXRb1 and RXRg were cloned from liver tissue and 
inserted into the pSC-B-RXR-hinge-LBD, and subsequently pCMX-GAL4-RXR-hinge-LBD. Sanger sequencing 
was used to verify incorporation of gmRXRb1/g into the plasmids. gmRXRb1/g transfected COS-7 cells were 
further utilized to verify synthesis of gmRXR fusion proteins, measure OTCs and 9-cis-RA mediated activation of 




3.2 Bioinformatical analyses  
3.2.1 Locating gmRXR isoforms in the Atlantic cod genome  
Well-annotated RXRa, RXRb1, RXRb2 and RXRg sequences from various species were 
obtained from UniProt, including Homo sapiens, D. reiro, S. salar and Rattus norvegicus. 
Protein Blast ® (NCBI) searches against the Atlantic cod genome (taxonomy identification 
8049) using these RXRs as queries were used to identify and locate the Atlantic cod isoforms 
(gmRXR). Protein Blast ® output provides percentage identity and query cover, along other 
information, allowing selection of predicted gmRXR sequences. Predicted gmRXRa, 
gmRXRb1, gmRXRb2 and gmRXRg were identified from these Blast searches. Genome Data 
Viewer (NCBI) was used to find the chromosomal location of the genes encoding the different 
isoforms. 
 
The DNA sequences encoding the putative RXR proteins were extracted from GenBank ® 
(NCBI) by using the accession number attached to the Blast-obtained hits. Expasy (SIB) 
translate tool was used to translate the DNA sequences into amino acid sequences.   
 
3.2.2 Multiple sequence alignment and phylogenetic analysis 
Multiple sequence alignments (MSA) were produced in Clustal Omega (EMBL-EBI) by using 
RXR protein sequences from Atlantic cod and a diverse set of other organisms. Jalview 2.11.1.4 
was used to visualize the alignment.  
 
A phylogenetic analysis was performed to categorize the different gmRXR isoform sequences 
into their specific isoforms. A comprehensive MSA including the predicted gmRXR proteins 
and RXR sequences obtained from variety of other species was generated in Clustal Omega 
(EMBL-EBI). Phylogenetic analysis provides different outputs representing the evolutionary 
history between subjects. In this study a phylogenetic tree was produced to visualize the 
evolutionary relationship of different RXR isoforms from different species, subsequently 
categorizing them based on sequence homology. MEGAX (PSU) was used to produce a 
maximum likelihood tree, which allowed categorization of the gmRXR isoform as gmRXRa, 




3.2.3 Annotation of DBD, hinge and LBD 
RXR protein sequences from H. sapiens and D. rerio containing well-annotated DBD, hinge-
region and LBD, were obtained from UniProt. A MSA was then produced with Clustal Omega 
using the annotated domain sequences and the gmRXR sequences. From the MSA, the DBD, 
hinge-region, and LBD were identified and defined in the gmRXR isoforms.  
 
3.2.4 Exon-intron mapping 
To map the exon-intron boarders in the gmRXR-encoding genes, the Ensembl (EMBL-EBI) 
genome browser was used. The gene ID of the different gmRXR isoforms were used as search 
inputs. Ensembl provides a vast array of sequence information including intron and exon 
sequences. WormWeb v.4. was used to illustrate the exon-intron boarders.  
 
3.3 Complementary DNA synthesis  
Complementary DNA (cDNA) was synthesized by the reverse transcriptase enzyme using RNA 
as template and the cDNA synthesis protocol provided by iScriptTM. The RNA templates 
consisted of elven different tissue samples from three individual juvenile female Atlantic cod 
(denoted as TB3, TB4 and TB5), obtained from preexisting RNA tissue bank in our laboratory. 
The tissue samples were from ovary, muscle, head kidney, skin, spleen, heart, stomach, liver, 
brain, gill, and eye. The iScriptTM cDNA synthesis kit includes a reverse transcriptase, a reaction 
mix, and a RNase-inhibitor. The reaction mix include components such as dNTPs, primers, and 
a buffer. Of the primers in the reaction mix, there are two types: oligio(dT)-primer and random 
hexamer. Oligio(dT)-primers are rich in thymine acting as hybridization probes that bind and 
hybridize poly-A tales in mRNA. The random hexamer consists of six random oligonucleotides 
able to bind mRNA on different locations. The reaction mix, reverse transcriptase and MQH2O 
was first mixed without template and incubated at 70°C for 5 min and then left on ice. The RNA 
was then added, and the mix was centrifuged, before polymerase chain reaction (PCR) was 








Table 34. Protocol followed for cDNA synthesis with qScript Kit 
Reagents  Volume Concentration  
RNA template  - 1 µg 
qScript Reaction Mix (5x) 4 µL 1X 
qScript Reverse Transcriptase  1 µL 1X 
MQH2O To 20 µL - 
 
Table 35. PCR-program 
Temperature  Time Cycles  
25°C  5 min  
46°C 30 min  1 
96°C 1 min  
 
3.4 Polymerase chain reaction  
Polymerase chain reaction (PCR) is a method in which a vast amount of specific, and 
unspecific, DNA sequences can be produced from a primary pool by using single stranded DNA 
primers. The PCR protocol used was a three step PCR where cyclical events of denaturation, 
annealing and elongation occurs to produce DNA copies. During denaturation, the DNA is 
normally heated to 95°C, where the double helix is broken into two separate strands. During 
annealing, temperatures are lowered to the optimal temperature in which primers most 
efficiently bind to 5´-DNA and 3´-DNA. Elongation is the final step where temperatures are 
increased to 72°C as it is the optimal temperature for DNA-polymerase binding and activation. 
The DNA-polymerase synthesize new strands, allowing double helixes to form and the number 
of DNA helices are now doubled. This is cycle is repeated until the desired amount of DNA is 
produced, typically 20-40 cycles.  
 
3.5 DNA-electrophoresis 
Agarose gen electrophoresis was used to analyze amplified DNA (PCR products). 
Electrophoresis uses agarose gels to separate differently sized DNA strands based on size-
dependent migration through an electric field. Due to DNAs negative charge, it will migrate 
towards a positive electrode, with smaller molecules able to migrate longer distances through 
the porous agarose gel.   
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Agarose and 0,5 X TBE buffer was mixed and heated to produce 0.5-2% agarose gel, as desired. 
0,5 µL or 0,7 µL GelRed was added to 30 ml or 50 ml agarose gels, respectively, before agarose 
was left to polymerize. GelRed, is a fluorescent nucleic acid dye used to stain DNA. Once set, 
0,5 X TBE buffer was added on top of the gel. The PCR product mixed with 10X loadingbuffer 
was then loaded into wells in the agarose gel. 10 X loadingbuffer was used to ensure samples 
descending to the bottom of the wells. A 2-log DNA ladder was used as a size marker. The gel 
was running at 80-100V for 30-45 min and visualized with a ChemiDoc XRS+ (Bio-Rad) 
instrument. 
 
3.6 Gel extraction of DNA 
Gel extraction of DNA was done using NucleoSpin® Gel and PCR Cleain-up (Macherey-
Nagel). To extract DNA from an agarose gel and further purify the product, the gel was first 
placed at a UV-table which allowed visualization of the DNA bands. The desired DNA band(s) 
were then cut out using a scalpel, transferred to an Eppendorf tube, mixed with a guanidium 
chloride-based buffer and heated at 50°C until gel was dissolved. The DNA was then transferred 
to a column containing a silicon membrane allowing DNA to bind the membrane, where it was 
washed and centrifuged. DNA was eluted using a Tris-HCL buffer. A Nanodrop1000 
instrument was used to measure the concentrations of DNA achieved from the extraction.  
 
3.7 Quantitative polymerase chain reaction (qPCR) assay 
Quantitative polymerase chain reaction (qPCR), or real-time polymerase chain reaction (RT-
PCR) as it is also called, is based on the same principles as PCR. However, qPCR uses in 
addition a fluorescent agent allowing quantification and detection of DNA amplified in each 
cycle.  
 
3.7.1 Primer design  
To amplify gmRXR transcripts, a specific primer pair of forward (5´) and reverse (3´) primers 
were designed for RXRa, RXRb1, RXRb2 and RXRg. To ensure optimal and specific binding 
to cDNA template the primers consisted of 18-30 nucleotides, a GC (guanine-cytosine) content 
of 40-60%, and a melting temperature (Tm) no less than 4°C between the primer pairs. The 
primers were designed in Primer3web version 4.1.0. Primers were tested through PCR 
amplification and visualized on a 2% agarose gel. 
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Table 36. Primer sequences used for qPCR assay.  






















Table 37. Reagents for PCR used to test primers 
Reagents  Volume  Concentration  
Lightcycler ® SyBR green master mix  10 µL 1X 
Template (cDNA) - - 
Primer (F+R) 1 µL 0,5 µM 
MQH2O To 20 µL - 
 
Table 38. PCR program  
Temperature  Time Cycles  









72°C 5 min - 






3.7.2 qPCR protocol  
LightCycler®480 SYBR Green I Master (Rocher) was used as a fluorescent agent. In a 96-well 
plate, 5 µL of the different tissue templates (cDNA) was mixed with 15 µL reaction mix and 
added to each well. The reaction mix consisted of 0,5 µM total forward and reverse primers and 
10 µL master mix. To fit everything in one 96-well plate, tissue samples derived from 
individuals TB4 and TB5 were added to the 96-well plate in triplicates (i.e., TB4 in wells A1-
D5 and TB5 in wells E5-H9) and TB3 in duplicates (wells A10-H12). A plastic seal was added, 
before centrifuging the plate at 500 rpm for 3 minutes. The plate was then transferred to the 
C1000™ Thermal Cycler using the program found in Table 39. To ensure purity and specificity 
of primers used in qPCR a melting curve analysis was performed. A melting curve obtained 
with a specific primer pair will consist of only one peak, while non-specific primer pairs will 
consist of two or more peaks due to differences in the Tm of the products the primers have 
produced. In this study, tissue specific expression of the Atlantic cod RXR isoforms was 
examined. A no template qPCR reaction was performed and used as a negative control. Further, 
the housekeeping gene b-actin was used to later normalize the tissue specific expression across 
samples. 
 
Table 39. qPCR program  
Step  Temperature  Time  Cycles  



























3.7.3 Efficiency of primer pairs  
A standard curve was produced to determine the efficiency of the primer pairs. Gel-extracted 
PCR products from initial primer testing was used as templates. The DNA was diluted 1/10 
with a subsequent 2-fold serial dilution. Reaction mix was added, and qPCR was done using 
the same protocol as described in Table 38. From the standard curve, the amplification-
efficiency (E) for each primer were verified to be withing the desired 90-110% range (E-value 
between 1,9-2,1).   
 
3.7.4 Analyzing qPCR data  
To calculate normalized tissue expression of gmrxr isoforms in Atlantic cod tissue, the DCq 
method (Livak & Schmittgen) was used (Formula 1). This method uses differences in Cq-values 
between reference genes and target genes for each sample. Cq-values are defined as the number 
of cycles needed for fluorescent signal to exceed background fluorescence. Normalized tissue 
expression was calculated in Microsoft Excel and visualized using GraphPad Prism 9. 
 
Formula 1. Normalizing tissue specific expressions of gmRXR in in Atlantic cod tissues 




















3.8 Blunt cloning and pCMX-GAL4-RXR construction   
3.8.1 Primer design   
Individually designed primes were used for incorporation of gmRXRb1- and gmRXRg-hinge-
LBD sequences into a pSC-B vector (Methods 3.8.2-3.8.4), and subsequently when 
constructing the pCMX-GAL4-RXRb1/g-hinge-LBD (Methods 3.8.6-3.8.8). The primers 
designed and used in cloning followed the same criteria as those of the qPCR in order to achieve 
optimal template binding. These primers were 18-30 nucleotides long, a GC content between 
40-60% and no less than 4°C Tm difference between the primer pair. The forward primer was 
placed at the N-terminal of the hinge-region with the reverse primer at the far C-terminal of the 
LBD. SnapGene 5.3 software was used for primer design where secondary structure prediction 
and in silico cloning simulation was performed.  
 
Another feature of the cloning primers is the introduction of recognition sequences for 
restriction enzymes with an additional random 6bp tail. Restriction enzymes are endonucleases 
that can recognize and cut specific DNA sequences. To construct the pCMX-GAL4-RXR-
hinge-LBD plasmids, restriction enzymes was used to cut and ligate the gmRXR hinge-LBD 
sequences into pCMX-GAL4 plasmids. In the primers used, EcoRI and NheI recognition 
sequences were introduced in the forward and reverse primers respectively. Primers was tested 
using PCR and a 0,7% agarose gel.  
 
Table 40. Primers designed and used for producing gmRXR-hinge-LBD fragments 
Primer  Sequence 5´à3´ 
gmRXRb1 fwd ggaaccGAATTCAAGGCTCTTGCGGTGCAGGA 
gmRXRb1 rev cgagtcGCTAGCCTAAGATAACTGGTGGGGCGCTTCAAG 
gmRXRg fwd gcagcaGAATTCAAGAGAGAAGCGGTGCAGGA 









Table 41. Reagents for PCR used to test cloning primers 
Reagents  Volumes  Concentrations  
5X Phusion HF buffer 10 µL 1X 
dNTP 4 µL 200 µM 
Template  - - 
Phusion hotstart polymerase 0,5 µL 1U 
Primer (F+R) 2,5 µL 10 µM 
MQH2O To 50 µL - 
 
Table 42. PCR program  
Temperature  Time Cycles  









72°C 5 min - 
4°C - - 
 
3.8.2 Blunt PCR cloning and transformation of Escherichia coli  
Blunt cloning was a procedure used to clone gmRXR-PCR-products into pSC-B vectors. The 
StrataClone Blunt PCR cloning kit (Agilent) was used. Purified PCR products extracted from 
agarose gel were added to cloning buffer and vector mix from supplier. The lysis mix was 
incubated at RT°C for 5 min and then put on ice.  
 
The cells used were provided by StrataClone and are competent E. coli cells submerged in a 
saline solution to increase absorption of extracellular DNA, e.g., PCR product. By adding PCR 
product to cell mix on ice, DNA binding to cells is promoted and subsequent heating causes a 
change in membrane fluidity allowing bound DNA to be absorbed completely by the cells.  
 
The Strataclone E. coli cells were stored at -80°C and thawed on ice before 1 µL ligation mix 
was added to the cells. The ligation mix consisted of 3 µL blunt cloning buffer, 2 µL extracted 
PCR product and 1 µL blunt vector mix. The cell-mix was incubated on ice for 20 min, and 3 
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mL of LB-medium was pre-warmed in a water bath at 42°C. After incubation, the cell-mix was 
heatshocked by submerging in the 42°C water bath for 45 sec, before being incubated on ice 
for 2 min directly after. 250 µL of the prewarmed LB-medium was added to the cell-mix and 
centrifuged at 250 rpms for 1,5h. 40 µL 2% X-gal was smeared out on duplicate agar-plates. 5 
µL cell-mix+50 µL LB-medium was added to half the duplicate plates and 100 µL cell-mix to 
the other. A sterilized glass rod was used carefully to evenly distribute the content on the agar 
plates. The plates were then incubated at 37°C until enough transformed E. coli colonies had 
been produced. 
 
Table 43. Reagents for blunt cloning and screening of PCR product  
Reagents  Volume  
StrataClone competent E. coli - 
StrataClone blunt cloning buffer  3 µL 
Gel/PCR product  2 µL 
Strataclone blunt vector mix 1 µL 
LB-medium - 
2% X-gal 40 µL 
 
3.8.3 Blue-White screening 
Blue-White screening is a method used to efficiently differentiate between transformed and 
non-transformed bacterial colonies. In this study 2% X-gal was used as screening agent. In 
colonies formed by non-recombinant cells X-gal is hydrolyzed by b-galactosidase to form 5-
bromo-4c-chloro-indoxyl which dimerizes to produce a blue pigment (5,5´-dibromo-4´4-
dichloro-indigo). In recombinant cells, the plasmid (pSC-B) is manipulated to disrupts a-
complementation leading to no functional b-galactosidase synthesis. This causes recombinant 
colonies to have a pale appearance and can be isolated and purified through miniprep.  
 
3.8.4 Colony PCR 
This method is used to assess transformed bacteria to verify the existence of a desired 
introduced genetic construct. Here, a portion of the construct is amplified using PCR. In this 
study it was used to verify the insertion of a product into the pSC-B and pCMX-GAL4-DBD 
plasmids. Colonies grown on agar plates are used as templates where the desired colonies are 
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poked using a pipette tip and mixed with 5 µL MQH2O. 1 µL of colony+MQH2O was then 
added to a master-mix and amplification was done with PCR. Agarose gel electrophoresis with 
a 0,7% agarose gel was used to confirm the presence of an inserted DNA fragment.  
 
Table 44. Colony PCR reagents used for both pSC-B-RXR and pCMX-GAL4-RXR 
Reagents  Volumes  Concentrations  
10X DreamTaq Green Buffer 1 µL 1X 
dNTP 0,8 µL 200 µM 
Primer (F+R)  0,5 µL 10 µM 
Template - - 
DreamTaq DNA polymerase 0,05 µL 1,25U 
MQH2O To 10 µL - 
 
Table 45. Primers used for colony PCR of pSC-B and pCMX-GAL4 plasmids 
Primer  Sequence 5´à 3´ 
pSC-B MT41 (F)  ATTAACCCTCACTAAAGGGA 
pSC-B MT42 (R) TAATACGACTCACTATAGGG 
pCMX-GAL4 MT1077 (F) TGCCGTCACAGATAGATTGG 
pCMX-GAL4 MT 1279 (R) AATCTCTGTAGGTAGTTTGTCCA 
 
Table 46. Colony PCR program for both pSC-B-RXR and pCMX-GAL4-RXR 
Temperature  Time Cycles  









72°C 5 min - 






3.8.5 Plasmid purification 
Two methods of purifying plasmid DNA were used during construction and sequencing of 
plasmids vectors, including miniprep and midiprep. Both methods include growing cells in LB-
medium with added antibiotics (ampicillin), centrifugation, and addition of a resuspension 
buffer. The cells are further lysed and added a neutralization buffer where chromosomal DNA 
and other cellular components are liberated, and plasmid DNA can retain a supercoiled 
conformation. Liberated cellular components are precipitated through centrifugation and 
plasmid DNA is isolated and added to a silica-based membrane allowing the DNA to bind. 
Further, a washing step containing ethanol-based buffer is used to remove impurities from the 
membrane. Finally, a slightly alkaline elution buffer (AE-buffer) is used to free purified DNA 
from the membrane. Midiprep has an additional cleaning step in which DNA is precipitated 
with isopropanol, centrifuged, washed with ethanol and then dried. A Nanodrop1000 
instrument was used to measure concentrations of plasmid DNA.  
 
Miniprep was used to purify plasmid-DNA used in construction and sequencing of pSC-B-RXR 
and pCMX-GAL4-RXR-hinge-LBD plasmids. Cells containing plasmids were added to 3 mL 
of LB-medium containing ampicillin (0,1 mg/mL) and incubated on a shaker at 250 rpm for 
24h at 37°C. NucleoSpin ® kit (Macherey-Nagel) was used and the protocol from the 
manufacturer was followed, where final purified DNA was eluted in 50 µL AE-buffer.  
 
Midiprep was used for purification of the pCMX-GAL4-RXR-hinge-LBD plasmids, the 
luciferase reporter plasmid and the b-galactosidase normalization plasmid, which all are used 
in the luciferase reporter gene assays. Cells containing the desired plasmids were added to 200 
mL LB-medium containing ampicillin (0,1 mg/mL) and placed in a 37°C incubator at 250 rpm 
for ~24h. Ultraspec 10 Cell Density meter (Amersham Biosciences) was used to measure cell 
density. Optical density volume (ODV)=200 was calculated, and the midiprep purification was 
further performed using instructions from the Plasmid DNA purification NucleoBond ® PC100 
kit (Macherey-Nagel).   
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3.8.6 Restriction enzyme double digestion  
 
Figure 9. Simplified visualization of pCMX-GAL4-RXRb1/g-hinge-LBD plasmids with restriction enzyme 
recognition sites used in digestion reactions. 
 
 
To allow incorporation of the gmRXR-sequences into the pCMX-GAL4-DBD, both a pCMX-
GAL4-DBD plasmid and the pSC-B-RXRb1/g were digested using two restriction enzymes 
(EcoRI and NheI). Recognition sequences for the restriction enzymes are preexisting in pCMX-
GAL4-DBD plasmid and introduced to gmRXR through the primers designed. The digestion 
reaction was incubated at 37°C for 3h. A dephosphorylation agent (SAP) was added 45 min 
before incubation end to dephosphorylate the plasmid. SAP removes the 5´-phosphate group 
created during the digestion reaction to inhibit relegation of linearized pCMX-GAL4-DBD. 
Dephosphorylation reactions was ended by adding the digest mix to a 65°C heating block for 
15 min. 10 X loading buffer was added to the digest and an agarose gel were used to locate the 
digested pCMX-GAL4-DBD and gmRXR. Using a UV-table, the corresponding bands were 











Table 47. Reagents for double digest with restriction enzymes 
Reagent   Volume  Concentration  
EcoRI 1 µL 0,375 U/µL 
NheI 1 µL 0,375 U/µL 
10X Buffer M 4 µL 1X 
Template (pCMX or RXR) 1 µL 10µg/40 µL (pCMX) or 2µg/40 µL (RXR) 
MQH2O 33 µL - 
SAP  1,3 µL 1U 
 
3.8.7 Ligation 
To construct the pCMX-GAL4-RXR-hinge-LBD plasmids after restriction enzyme digestion, 
the products extracted from gel (digested plasmid and gmRXR) was ligated. The ligation 
reaction uses the enzyme T4 DNA-ligase, which promotes production of phosphodiester bonds 
between phosphate and hydroxyl groups in DNA. A ligation reaction mix consisting of pCMX-
GAL4-digest, gmRXR-digest, T4-ligase, 10 X T4 DNA-ligase buffer and MQH2O was 
produced and incubated at 4°C for ~15h. Reaction was terminated through a 15 min incubation 
in a heating block at 65°C.  Formula 2 was used to calculate the mass of inserted DNA needed 
for the ligation reaction, where a 3:1 molarity ratio was used of inserted gmRXR fragment 
compared to pCMX-GAL4-digest.  
 
Formula 2. Calculating the molecular mass of DNA for pCMX-GAL4 insertion. 
𝑀𝑎𝑠𝑠(𝑛𝑔) = 𝑚𝑜𝑙𝑎𝑟	𝑖𝑛𝑠𝑒𝑟𝑡𝑖𝑜𝑛 ∗ 𝑚𝑎𝑠𝑠	𝑜𝑓	𝑣𝑒𝑐𝑡𝑜𝑟	(𝑝𝐶𝑀𝑋 − 𝐺𝐴𝐿4) ∗ 𝑟𝑎𝑡𝑖𝑜	𝑜𝑓	𝑖𝑛𝑠𝑒𝑟𝑡𝑖𝑜𝑛	𝑎𝑛𝑑	𝑣𝑒𝑐𝑡𝑜𝑟	𝑙𝑒𝑛𝑔𝑡ℎ	  
 
Table 48. Reagents for ligation protocol  
Reagent  Volume  Concentration/amount 
Digested RXR - - 
Digested pCMX-GAL4 - 25 ng 
10X T4 DNA ligase buffer 1 µL 1X 
T4 ligase 1 µL 17,5 U/µL 





3.8.8 Transformation of plasmid construct 
To transform the plasmid constructs into E. coli cells, StrataClone competent cell Mix&Go was 
used. The cells were stored in -80°C and thawed on ice. 2 µL of ligation product was then added 
to cells and mixed carefully in. 5 µL cell mix and 15 µL LB-medium was then added to one 
agar plate, and 20 µL cell mix to another (no LB-medium). Both were evenly distributed by 
using a sterilized glass rod and incubated for 24-30h at 37°C. Colony PCR and agarose gel 
electrophoresis was then used to confirm transformants containing the pCMX-GAL4-RXR-
hinge-LBD plasmids. Plasmids was then purified using midiprep (method 3.7.8).  
 
3.8.9 Sanger sequencing 
Sequencing of pCMX-GAL4-RXR-hinge-LBD constructs were performed at the Department 
of Biological Sciences (UiB). Preparation of the sequencing reaction was done in accordance 
with the BigDye v3.1 protocol provided by UiB. The reaction setup and thermal cycle program 
is found in Tables 49 and 51, with template being the pCMX-GAL4-RXR-hinge-LBD 
plasmids. After PCR reaction is completed, 10 µL MQH2O is added to the product and sent for 
sequencing. Sanger sequencing is limited to 900bp where the primers used allowed sequencing 
of whole RXR insertion. Sequencing data was analyzed in SnapGene v5.3, where sequence 
output was aligned with predicted RXR sequences obtained from the cod genome.      
 
Table 49. Sanger sequencing preparation reagents using BigDye v3.1 protocol 
Reagents  Volume  Concentration  
Big Dye  8,5 µL 1U 
5X Sequencing buffer  8,5 µL 1X 
Template  - - 
Primer (F+R) 8,5 µL 3,2 µM 
MQH2O To 80 µL - 
 
Table 50. Primers used  
Primers  Sequence 5´à 3´ 
MT1077 (F) TGCCGTCACAGATAGATTGG 




Table 51. PCR program  
Temperature  Time  Cycles  
96°C 5 min - 
96°C 10 sec  
50°C 5 sec 25 
60°C 4 min  
4°C - - 
 
3.9 Western blot assay 
3.9.1 Sodium-dodecyl-sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) 
SDS-PAGE electrophoresis is a method to separate proteins according to their molecular size. 
The proteins are first denaturated at 95°C, mixed with a sample buffer containing b-
mercaptoethanol and SDS. b-mercaptoethanol acts as a reducing agent breaking disulfide 
bonds, while the anionic detergent SDS, promotes denaturation and coating of the peptides, 
producing a negatively charged polypeptide chain. The negative charge allows migration 
through a polyacrylamide gel for separation of differently sized proteins.  
 
3.9.2 Preparation of cell lysates 
COS-7 cells were seeded (Method 3.10.1) in 96-well plates and incubated for 18-24h. The 
following day, medium was discarded, and new medium added before COS-7 cells were 
transfected with the pCMX-GAL4-RXR plasmids (Methods 3.10.11). On day three, medium 
was once more discarded, and wells were washed with 100 µL 1 X PBS. 20 µL lysis reagent 
(Table 12) was then added to each well and incubated on ice on a shaker for 5min. The lysate 








3.9.3 Total protein staining 
A 1 mm thick polyacrylamide gel was casted and used for separation and visualization of total 
protein content. The gel was composed of a stacking gel and a separation gel that were 
transferred to an electrophoresis chamber after polymerization. The electrophoresis chamber 
was filled with appropriate volumes of 1 X TGS buffer. For protein molecular weight marker, 
5 µL Precision Plus Protein ™ Prestained Protein Standards was used. 20 µL cell lysate was 
added to four wells. The gel was run at 200V for 45-60 min. To visualize the protein content, 
the gel was placed in a container and further on a shaker at RT°C and stained with InstantBlue 
™ Coomassie Protein Stain (Expedeon) over night. Excess Coomassie was poured off and the 
gel was rinsed with ddH2O. A ChemiDoc XRS+ (Bio-Rad) instrument was used to photograph 
the stained gel.  
 
3.9.4 Western blotting 
Western blotting is a process also known as protein immunoblotting, in which specific proteins 
separated by SDS-PAGE can be detected through use of anti-bodies. In this study, Western 
blotting was used to verify the expression and synthesis of GAL4-RXR-hinge-LBD fusion 
proteins in transfected COS-7 cells. Mini Trans-Blot Electrophoretic Transfer Cell was used for 
western blotting. To prepare the western blot “sandwich”, a PVDF-membrane (9*6cm) was 
submerged in methanol for 20 sec and then washed with ddH2O. The membrane along the other 
sandwich components (two sponges and two filter papers) were submerged in transfer buffer 
for 15 minutes. The sandwich was then assembled in a specialized holder in the following order: 
spongeà paper àmembrane àgel àpaper àsponge. The holder containing the sandwich was 
then placed in the electrophoresis chamber filled with transfer buffer and containing two 
cooling units. The blotting was run at 100V for 50 min-1hour. The membrane was transferred 
to a container and blocked with 7% dry-milk in TBS-tween (TBS-T) and placed on a shaker at 
4°C overnight. The TBS-T+7% dry-milk was then poured off and the membrane was washed 
with TBS-T. Primary antibodies (mouse anti-Gal4-DBD) were diluted 1:500 in TBS-T and 
incubated at RT°C on a shaker for 1h. Excess/unbound primary antibody+TBS-T was poured 
of and the membrane was rinsed with TBS-T. Secondary antibodies (sheep anti-mouse IgG) 
was diluted 1:2000 in TBS-T and added to the membrane, placed on a shaker, and incubated 
for 1h at RT°C. Excess/unbound secondary antibody+TBS-T was poured of and washed with 
TBS-T. SuperSignal™ West Femto Maximum Sensitivity Substrate kit was used to visualize 
the GAL4-RXR-hinge-LBD fusion proteins. 3 mL solution was prepared, poured on the 
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membrane, and incubated at RT°C for 5 min. Protein bands were visualized with ChemiDoc 
XRS+ (Bio-Rad).  
 
b-actin was used as loading control as it is ubiquitously expressed in all eucaryotic cells. The 
same membrane from the western blot with the mouse anti-GAL4-DBD antibody, was used 
here. The membrane was washed in TBS-T, and primary mouse anti-b-actin antibody was 
diluted 1:1000 and poured over the membrane where it was incubated for 1h at RT°C on a 
shaker. Primary antibody+TBS-T was poured off and the membrane washed with TBS-T on a 
shaker for 10 min three times. Secondary antibody (Sheep-anti-mouse) was diluted 1:2000 and 
poured over membrane and incubated at RT on a shaker for 1h. The membrane was 
subsequently washed with TBS-T on a shaker for 10 min three times. SuperSignal ™ West 
Femto Maximum Sensitivity Substrate kit was added (3 mL), and the protein bands were 
visualized in ChemiDoc XRS+ (Bio-Rad).  
 
3.10 Luciferase reporter gene assay 
Luciferase reporter gene assays were used to measure ligand-induced activation of gmRXR. 
Here, COS-7 cells were transfected with a reporter-plasmid ((MH100)x4tkluc)) containing the 
luciferase reporter gene, a b-galactosidase-encoding normalization plasmid, and the pCMX-
GAL4-RXR-hinge-LBD receptor plasmid. Upstream activation sequences (GAL4-UAS) in the 
reporter-plasmid promotor region, regulates the transcription of the luciferase gene. Through 
binding of ligand, the translated reporter receptor (GAL4-RXR-hinge-LBD) will undergo 
confirmational changes allowing the reporter receptor to bind GAL4. The complex then binds 
to an upstream activation sequence (UAS), in turn promoting transcription and production of 
luciferase enzymes. The transcription and subsequent translation allow measurement of 
luciferase enzymatic activity, producing oxyluciferin and light (550nm-570nm) through 
interaction with luciferin substrates. The amount light produced from this reaction is quantified 
in a luminometer and correlates to the level of gmRXR activation. b-galactosidase is used to 
normalize the transfection efficiency of COS-7 cells. b-galactosidase produces ONP and 
galactose through hydrolysis of the substrate ONPG. ONP absorbs light at 420nm and levels of 
ONP can be quantified and correlated to b-galactosidase activity. An overview of the luciferase 





Figure 10. Overview of the GAL4-UAS based luciferase reporter gene assay. Receptor plasmids and reporter 
plasmids are transfected into cells, where the receptor-gene are constitutively expressed and translated into protein. 
When bound by ligand, the receptor protein goes through a conformational change and associates with GAL4-
DBD which further binds UAS in the reporter plasmid. Luciferase is subsequently synthesized, and the enzyme 
catalyze the conversion of luciferin into oxyluciferin and light (550nm-570nm). The figure is modified from 
Madsen (2016).   
 
3.10.1 Cultivation of COS-7 cells 
COS-7 cells were stored in a freezing medium submerged in liquid nitrogen. A vile of COS-7 
cells was removed from storage and quickly thawed before 10 mL of growth medium (DMEM-
10%FBS) was added and the COS-7-cells+medium was centrifuged for 5 min at 500 rpm (RT). 
Excess medium was removed before resuspending cells in fresh medium. Cells where then 
seeded in 10 cm petri dishes and incubated at 37°C with 5% CO2 until confluency of 70-90%. 
At this confluency medium was removed from dishes and cells were washed in 1X PBS twice. 
1.5 mL of Trypsine-EDTA (0,05% trypsin, 0,02% EDTA) was added to the Petridis and 
incubated for 45 sec, allowing cells to release. Trypsin-EDTA was removed by pipetting, and 
cells were resuspended in growth medium and transferred to new Petri dishes diluted 1:20. Petri 




3.10.2 Seeding COS-7 cells in 96-well plates 
When the COS-7 cells reached a confluency of 70-90%, determined through light microscopy 
(Leica DM IL inverted microscope), cells were washed, trypsinated and resuspended as 
described above. 50 µL of resuspended cell+medium was mixed with 50µL erythrosin-B and 
the cell density was determined with a hemocytometer (Marienfield) and light microscopy. 
Cells were seeded in 96-well plates at a cell density of 5000 cells per well with a total volume 
of 100 µL using growth medium. Cells were incubated at 37°C with 5% CO2 for 18-24h.   
 
3.10.3 Transfection  
A transfection mix consisting of Opti-MEM I, TransIT-LT1, plasmid mix was prepared and 
incubated at RT for 30min. The plasmid mix contained (MH100)x4 tk luc, pCMV b-Gal and 
pCMX-GAL4-RXRb1/g-hinge-LBD with a ratio of 10:1 of (MH100)x4 tk luc and pCMV b-
Gal compared to pCMX-GAL4-RXRb1/g-hinge-LBD. The transfection mix was added to the 
growth medium. Old medium was discarded from the 96-well plate and 101 µL transfection 
mix+growth medium was added to each cell and incubated at 37°C with 5% CO2 for 24h. 
 
Table 52. Amount of plasmid added to each well  
Plasmid  Amount  







Table 53. Reagents for transfection of COS-7 
Reagents  Volume per well  
Opti-MEM I 9 µL 
TransIT-LT1 0,3 µL 
Plasmid-mix 0,1 µL 






3.10.4 Ligand exposure 
Transfected COS-7 cells were exposed to ligands dissolved in DMSO at a dilution factor of 5 
in phenol-red free growth medium (DMEM-10% FBS w/o phenol red). A deep 96-well plate 
was used for the dilution series with concentrations of ligand declining from well A to G. Well 
H was used as a no-ligand control containing only growth medium and DMSO. The dilution 
series was made in a 2 X concentration. Growth medium from 96-well plate was discarded and 
100 µL 2 X dilution mix was added to their designated wells. 100 µL phenol-red free growth 
medium was mixed in the wells containing 2 X dilution mix, giving a final 1 X concentration 
of ligand. Final DMSO concentration was between 0.2-0.5%. Cells were incubated and exposed 
for 24h at 37°C with 5% CO2.  
 
Table 54. Serial diluted exposure ligands with dilution factor 5 (µM) 












A 20.0 0.5 0.5 0.5 0.5 0.5 
B 4.0 0.1 0.1 0.1 0.1 0.1 
C 0.8 0.02 0.02 0.02 0.02 0.02 
D 0.16 0.004 0.004 0.004 0.004 0.004 
E 0.032 0.0008 0.0008 0.0008 0.0008 0.0008 
F 0.006 0.00016 0.00016 0.00016 0.00016 0.00016 
G 0.001 0.00003 0.00003 0.00003 0.00003 0.00003 
 
3.10.5 Lysis and enzymatic measurements 
After 24h of exposure, the medium was discarded, and 125 µL lysis reagent solution was added 
to each well of the 96-well plate. The plate was put on a shaker at RT°C and incubated for 30 
min. The lysis buffer disrupts membrane integrity and inhibits protease activity, allowing the 
release of luciferase and b-galactosidase. 50 µL of lysate was transferred to a clear 96-well plate 
and a white luminescence 96-well plate for b-galactosidase and luciferase activity 
measurements respectively. 100 µL of b-galactosidase reaction solution was added to each well 
of the clear plate and incubated for 20 min or until a yellow color had formed. Enspire 2300 
plate reader (PerkinElmer) was used to measure absorption at 420nm. 100 µL of luciferase 
reaction solution was added to the white plate and immediately placed in the Enspire 2300 plate 
reader (PerkinElmer) for luminescence measurement. Luciferase activity was divided on 
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corresponding b-galactosidase activity to adjust for variability in transfection efficiency. A non-
linear regression curve was produced in GraphPad Prism 9 to visualize dose-response activation 
profiles induced by the different ligands.  
 
3.11 Cell viability assay 
A cell viability assay was used to assess the potential cytotoxic effect of the ligands used in the 
luciferase reporter gene assay. Here, a combination of resazurin and CFDA-AM was used as an 
indication of decreased metabolic activity and cell-membrane integrity respectively. A 96-well 
plate was seeded, including wells without cells. The empty wells were used to account for 
background signals. gmRXR transfected COS-7 cells were exposed to the three highest 
concentrations of ligand from the luciferase reporter gene assay and incubated at 37°C with 5% 
CO2 for 24h. 0.5 µL Triton X-100 was used as a positive control for reduced cell viability. 
Medium was then removed, and cells were washed with 1 X PBS before 100 µL of a 
rezasurin/CFDA-AM mixture was added to each well. The cells were incubated at 37°C with 
5% CO2 for 2h. Fluorescence signals were then measured using the Enspire 2300 plate reader 
(PerkinElmer) and 530/590nm (excitation/emission) for rezasurin and 485/530nm for CFDA-
AM. GraphPad Prims 9 was used for visualizing changes in metabolic activity and membrane 
















4.1 Bioinformatics  
4.1.1 Genome mining and phylogenetic analysis of the Atlantic cod RXR-isoforms  
Manually annotated RXR sequences from teleost and mammalian species, including species D. 
rerio, S. salar and H. sapiens, were used for homology searches in the Atlantic cod genome 
using the BLAST (NCBI) algorithm. Four predicted RXR encoding genes were identified 
(GeneID: LOC115532083, LOC115545518, LOC115535425 and LOC115555583). The 
deduced amino acid sequences from these genes were obtained and a phylogenetic analysis was 
performed to confirm the identification of these genes as gmRXR isoforms and investigate their 
evolutionary relationship. Hence, an MSA was constructed by using a vast array of RXR protein 
sequences, including the gmRXR isoforms from Atlantic cod and RXR sequences obtained 
from mammals (H. sapiens, Mus musculus, etc.) and teleost (D. rerio, S. salar, Esox lucius, 
etc.), including two other species from the Gadiformes order (Melanonus gracilis and 
Melanogrammus aeglefinus). From the MSA a maximum likelihood tree was produced, placing 
the different RXR isoforms based on their phylogenetic relations (Fig 11). The gmRXR proteins 
were found to be closely related to other well characterized RXRa, RXRb or RXRg isoforms, 
and were subsequently categorized accordingly. From this analysis, the four predicted Atlantic 
cod RXR isoforms were identified as gmRXRa (LOC115532083), gmRXRb1 
(LOC115545518), gmRXRb2 (LOC115535425) and gmRXRg (LOC115555583). The gmRXR 
isoforms were observed to primarily be closely related to species from the Gadiformes order, 
and further reflecting a close phylogenetic relationship to other teleost fishes, with mammalian 
RXRs being the most distantly related from an evolutionary perspective. Furthermore, the 
RXR-encoding genes were all located on different chromosomes, with gmRXRa located on 
chromosome 19, gmRXRb1 on chromosome 6, gmRXRb2 on chromosome 22 and gmRXRg 
on chromosome 12 (Fig 12). The gmRXR isoforms also varied slightly in length and the gene 
sequences revealed that gmrxra, gmrxrb, gmrxrb2 and gmrxrg  constituted of an open reading 
frame of 1515bp, 1323bp, 1400bp, and 1398bp, respectively. From the protein sequences, the 
molecular weight of the predicted gmRXR isoforms were calculated. Due to an elongated N-
terminal tail gmRXRa, which was not observed conserved in the other isoforms, this isoform 
was by far the largest at 63kDa (584 amino acids). gmRXRb2 and gmRXRg were found to be 
similar in size at approx. 52kDa (472 amino acids and 466 amino acids respectively), and 
gmRXRb1 were the smallest protein at 49kDa (441 amino acids). 
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Figure 11. Phylogenetic tree analysis of RXR. The phylogenetic tree is a maximum likelihood tree illustrating 
evolutionary relationship between the gmRXR-isoforms (boxed in red) and RXR-isoforms obtained from different 
species, as indicated. The clusters containing sequences belonging to either the RXRa, RXRb1, RXRb2 or RXRg 
isoforms are indicated to the right. Phylogenetic analysis was performed in MEGAX, including construction of 
the MSA using the Muscle algorithm.  
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Figure 12. Chromosomal location of RXR-isoforms in Atlantic cod. The 23 chromosome pairs of Atlantic cod 
are illustrated in grey with their chromosomal numbers indicated above. The genes encoding gmRXRa (green), 
gmRXRb1 (orange), gmRXRb2 (red) and gmRXRg (blue) are all located on distinct chromosomes, as indicated.  
 
4.1.2 gmRXR intron-exon mapping  
Exon and intron sequences from the gmrxr isoforms were derived from Ensembl. Cross-
referencing the predicted Ensembl exon sequences with the deduced protein sequences, verified 
that the exons belonged to the predicted gmRXR isoforms. From the genomic sequences, the 
number of exons, exon-intron borders and intron/exon sequence lengths were obtained (Fig 13). 
From this, gmrxra, gmrxrb, gmrxrb2 and gmrxrg were demonstrated to consists of 11, 11, 12, 
and 10 exons, respectively. The intronic sequences of gmRXRa were observed to be 




Figure 13. Illustration of intron-exon borders for the gmrxr-isoforms. Black boxes represent exons and 
connecting lines represent introns. gmrxra intron sequences are substantially longer compared to the other 
isoforms; the scale is 1000bp for gmrxra, while gmrxrb1, gmrxrb2 and gmrxrg are scaled with 100bp, as indicated 
with bars. Illustration was prepared using WormWeb GraphicMaker.  
 
 
4.1.3 Identifying the DBD, hinge and LBD of gmRXR isoforms 
Well characterized RXR sequences from D. rerio and H. sapiens were aligned with the protein 
sequences of the gmRXR isoforms for identifying the DBD, the hinge-region, and the LBD. 
From this MSA produced the DBD, hinge-region and LBD was located and annotated in the 
gmRXR proteins as shown in figure 14. In accordance with other nuclear receptors, the DBDs 
of the gmRXR isoforms was highly conserved when compared to one another (91.2%), while 
the hinge was poorly conserved and the LBD moderately conserved (63.38%). For the DBD, 
three subdomains important in DNA binding were located, including the T-, P-, and D-box. 
Further, 11 a-helices (H1, H3-H12) were also predicted and profiled in the gmRXR-LBDs 
based on previous studies of D. rerio RXR and H. sapiens RXR (Tsuji et al., 2015; Billas et al., 
2001). When comparing the domain sequences of gmRXR to corresponding D. rerio sequences, 
high level of conservation was observed. The DBDs sequence percentage similarity exceeded 




Figure 14. Multiple sequence alignment of the gmRXR-isoforms.  gmRXRa, gmRXRb1, gmRXRb2 and 
gmRXRg were aligned in Clustal Omega and visualized in JalView. Blue colored residues amino acid sequence 
percentage identity. Included in the alignment is the annotation of the DBD, the hinge-region, the LBD (including 
helices 1 and 3-12), P-box (red), D-box (orange) and T-box (green), annotated based on Tsuji et al., (2015) and 
Billas et al., (2001).  
 
 









4.2 Tissue specific expression of gmRXRa, gmRXRb1, gmRXRb2 and gmRXRg  
Synthesis of cDNA from RNA was performed as described in 3.3. The RNA originated from a 
total 11 different tissue types derived from three juvenile female Atlantic cod individuals. The 
cDNA was initially used in this study as template for primer pair testing, and subsequently in 
qPCR analyses to measure gmrxra, gmrxrb, gmrxrb2 and gmrxrg tissue expression in Atlantic 
cod. 
 
4.2.1 qPCR primer design and testing  
Primers used in the qPCR protocol were designed as described in 3.7.1. To ensure amplification 
of only targeted transcripts (i.e., gmrxra, gmrxrb1, gmrxrb2 and gmrxrg ) the specificity of the 
primer pairs was initially assessed with PCR. gmRXR isoforms were first amplified using liver 
cDNA as template and further separated on an agarose gel. Primer pairs yielding a singular PCR 
product at their calculated size were considered as well-suited candidates for qPCR. Primer 
pairs producing several bands would indicate multiple amplification sites as a result of 





Figure 15. PCR amplification of gmrxr isoforms using primers designed for qPCR. 2µL amplified gmrxr 
PCR-product was added to each well and separated in an 2% agarose gel. GelRed was added during preparation 
of the agarose gel for visualizing (GelRed) DNA fragments. 2 Log molecular weight standard was used to verify 
expected size of the PCR product corresponding to the gmrxr isoforms. Red boxes indicate the corresponding 
primer pairs used in melt-curve analysis (Appendix Fig 28). Primers tested that was not used, are not named in 
this thesis. Primers tested that was not used, are not named in this thesis.  
 
 
One promising primer pair for each of gmrxra, gmrxrb1, gmrxrb2 and gmrxrg (Fig 15), was 
chosen for the melt-curve analysis to further confirm specific amplification of a singular desired 
qPCR product. The melting curves for the different primer pairs were produced using the qPCR 
protocol (3.7.2) and liver tissue cDNA as template (Appendix Fig 28). The four primer pairs, 
representing the different gmRXR isoforms, were all observed to produce a single peak in the 
melting curve analyses. Based on the agarose gel electrophoresis and the melting curve analyses 




4.2.2 Tissue specific expression profiles of gmrxra, gmrxrb1, gmrxrb2 and gmrxrg 
Differences in tissue expression of gmrxra, gmrxrb1, gmrxrb2 and gmrxrg in Atlantic cod was 
analyzed using the protocol for qPCR (3.7.2-3.7.4) and actb2 was used as a housekeeping gene 
for normalization of the transcript levels. The tissues analyzed included ovary, muscle, head 
kidney, skin, spleen, heart, stomach, liver, brain, gill and eye. The qPCR data revealed 
significantly different expression profiles (Fig 16). gmrxra was expressed in significantly lower 
levels in all tissues compared to the other gmrxr isoforms. Although not discernible in figure 
16, gmrxra was expressed in all tissues apart from muscle and stomach (Appendix Fig 29).  
gmrxrg and gmrxrb2 had a relatively ubiquitous expression profiles at moderate levels, while 
gmrxrb1was expressed at highest levels in most tissues. 
 
 
Figure 16. Normalized mRNA expression of gmrxr isoforms in different tissues of Atlantic cod. qPCR was 
used to quantify the levels of gmrxr-isoform transcripts in the following tissues: ovary, muscle, head kidney, skin, 






4.3 Blunt-end cloning and construction of pCMX-GAL4-RXRb1-hinge-LBD plasmids 
and pCMX-GAL4-RXRg-hinge-LBD expression plasmids 
Due to time constraints of this study, it was not feasible to produce expression plasmids and 
perform ligand activation analyses of all four gmRXR-isoforms. Based on the tissue specific 
expression profiles (Fig 16), gmRXRg and gmRXRb1 were the most prominent isoforms 
expressed in Atlantic cod liver and were thus selected for further testing throughout this study. 
Liver expression was the deciding factor as it is highly relevant within the field of toxicology, 
representing the major detoxifying organ for exogenous compounds, including OTCs.  
 
4.3.1 Testing primers containing restriction enzyme recognition sequences   
Primers used for blunt PCR cloning and construction of pCMX-GAL4-RXRb1/g-hinge-LBD 
plasmids were designed as described in 3.8.1, by introducing the EcoRI and NheI recognition 
sequences. Forward primers were placed at the N-terminal end of the hinge region, while 
reverse primers were designed to align at the far end of the C-terminal of the LBDs. This would 
ensure amplification of full length gmRXR-LBDs and subsequent incorporation into pCMX-
GAL4 plasmids fused to the GAL4-DBD. Using liver cDNA as template, the hinge-LBD 
encoding DNA fragment of gmRXRb1 and gmRXRg were amplified using PCR and separated 
on an 0.7% agarose gel (Fig 17). The PCR-products of gmrxrg and gmrxrb were calculated to 
be approximately 800bp and 830bp, respectively. The primer pairs producing a singular DNA 
fragment for gmrxrg and gmrxrb1 and were thus used further and correspond to the primers 
given in Table 40.  
 
 
Figure 17. Amplification of gmRXRb1/g-hinge-LBD used in cloning and construction of both pSC-B-RXR-
hinge-LBD and pCMX-GAL4-RXR-hinge-LBD. The hinge region and LBD of gmRXRb1 and gmRXRg was 
amplified with PCR and 5µL PCR-product was applied to a 0.7% agarose gel for separation and visualization 





4.3.2 Construction of pSC-B-RXRb1/g -hinge-LBD  
Amplified PCR products of the hinge-LBD of gmRXRb1 and gmRXRg were directly ligated 
into the cloning plasmid (pSC-B) using blunt-end cloning (3.8.2). pSC-B-RXRb1/g-hinge-LBD 
plasmids were then transformed into competent E. coli cells (3.8.8), which were cultivated o/n 
and screened using blue-white screening with X-gal. Six white colonies were then randomly 
chosen for each isoform and analyzed with colony PCR. PCR products was separated on an 
agarose gel to confirm positive transformants. Figure 18 show that all colonies analyzed had 
incorporated a fragment of approx. 800bp in size, in accordance with the predicted size of 
gmRXRb1-hinge-LBD (~830bp) and gmRXRg-hinge-LBD (~800bp). One colony for 
gmRXRb1-hinge-LBD and one for gmRXRg-hinge-LBD was selected for further plasmid 




Figure 18. PCR-screening for positive pSC-B-RXRb1/g-hinge-LBD transformants. To confirm successful 
integration of gmRXRb1/g-hinge-LBD in pSC-B plasmid after blunt-end cloning, colony PCR was performed. Six 
colonies for both the gmRXRb1hinge-LBD and gmRXRg-hinge-LBD cloning were identified from blue-white 
screening and selected at random. gmRXR fragments was amplified using PCR, and further separated in an 0.7% 
agarose gel before visualization (GelRed). Expected DNA fragment size was ~850bp. 2Log molecular weight 




4.3.3 Construction of the pCMX-GAL4-RXRb1/g-hinge-LBD plasmids  
To construct the pCMX-GAL4-RXRb1/g-hinge-LBD expression plasmids, double digestion 
reactions were performed using the restriction enzymes corresponding to the primer-introduced 
recognition sites from the initial blunt-end cloning step. Thus, EcoRI and NheI was used as 
restriction enzymes for digesting both pSC-B-RXRb1/g-hinge-LBD and the previously 
constructed plasmid pCMX-GAL4-AHR2, yielding compatible ends during ligation. SAP was 
added to inhibit religation of linearized DNA. The pCMX-GAL4-AHR2 plasmid was used to 
more efficiently locate the pCMX-GAL4 empty vector fragment after AHR2 removal, which 
was needed for correct gmRXRb1/g-hinge-LBD insertion during ligation. The digested 
plasmids were separated on an agarose gel for visualization. Figure 19 shows the pSC-B-
RXRb1/g-hinge-LBD plasmids after digestion reaction where the lowest bands represent 
gmRXRb1/g-hinge-LBD fragments (~850bp). These fragments were extracted from the 
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agarose gel. Double digested pCMX-GAL4-AHR2 were also separated on an agarose gel, and 
the band marked with a red box in figure 20 represented empty pCMX-GAL4-DBD (4500bp). 




Figure 19. Restriction enzyme digestion of pSC-B-RXRb1/g-hinge-LBD plasmids. The fragments 
corresponding to the gmRXRb1/g-hinge-LBD were digested out from the pSC-B-gmRXRb1/g-hinge-LBD 
plasmids using EcoRI (3´end) and NehI (5´end) restriction enzymes. Confirmation of successful digestion reaction 
was done by separation of digestion products on a 0.7% agarose gel. The slowest moving band (>3000bp) 
represented undigested pSC-B-RXRb1/g-hinge-LBD and empty pSC-B (size difference too small to differentiate 
the two DNA fragments) and the lower band (<1000bp) represent the gmRXRb1/g-hinge-LBD fragment. 2 Log 





Figure 20. Restriction enzyme digestion of the pCMX-GAL4-AHR2 plasmid. Using EcoRI (3´end) and NehI 
(5´end) restriction enzymes, pCMX-GAL4-AHR2 was digested. The result of the digestion reaction was assessed 
using a 0.7% agarose gel. Empty pCMX-GAL4 plasmid is marked with a red box. Several fragments appear on 
the gel due to internal restriction enzyme sites in the AHR2 fragment. 2 Log molecular weight standard was used 
to verify expected size digestion reaction products. 
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Extracted gmRXRb1/g-hinge-LBD and empty pCMX-GAL4-DBD fragments were then mixed 
and ligated (3.8.7), and the ligation products were used to transform competent E. coli cells 
(3.8.8). The transformed E. coli cells was then cultivated and grown on agar plates. To increase 
the likelihood of selecting positive transformants, a large variety of colonies were selected. 
From the agar plates, 34 colonies were randomly picked for transformants containing gmRXRg-
hinge-LBD and 28 for gmRXRb1-hinge-LBD. Cloning primers (Table 40) and PCR were used 
to amplify the gmRXRb1/g-hinge-LBD fragment for identifying successfully transformed 
colonies. As there was some variety among the colonies, i.e., producing PCR fragments of 
>1000bp and <800bp in size (Fig 21), three colonies producing the >1000bp fragments, and 
three colonies producing the <800bp fragments were selected at random for both gmRXR 
isoforms and further purified using the midiprep protocol (3.8.5).  
 
 
Figure 21. Screening of pCMX-GAL4-RXRb1/g-hinge-LBD transformed E. coli using colony PCR. pCMX-
GAL4-RXRb1/g-hinge-LBD was transformed into E. coli cells and grown on agar plates o/n. Colonies grown were 
selected for both gmRXRb1-hinge-LBD and gmRXRg-hinge-LBD insertion. The RXRb1/g-hinge-LBD fragments 
were amplified using the colony PCR (3.8.4) and the PCR products were separated and visualized using a 0.7% 
agarose gel. 2 Log molecular weight standard was used to verify expected size of the RXRb1/g-hinge-LBD 
fragments. From the agarose gel, three colonies producing fragments >1000bp and three colonies producing 
fragments <800bp were chosen at random for further purification and Sanger sequencing. 
 
4.3.4 Sequencing pCMX-GAL4-RXRb1/g-hinge-LBD plasmids  
The six purified pCMX-GAL4-RXRb1/g-hinge-LBD plasmids from 4.3.3 were prepared for 
Sanger sequencing. Sequencing of pCMX-GAL4- RXRb1/g-hinge-LBD was performed at UiB 
in both directions, by using plasmid specific forward and reverse primers. Sequencing results 
from the triplicate colonies forming DNA fragments at <800bp, showed that the RXRb1/g-
hinge-LBD sequence was fully incorporated to the pCMX-GAL4-DBD plasmid. The colonies 
forming fragments >1000bp were not used, as they contained additional nucleotides upstream 
from the hinge-region. gmRXRb1-hinge-LBD was observed to have obtained a single point 
mutation of an adenine to a guanine in comparison to the genomic sequence. However, this 
proved to be a silent mutation and should therefore not have an impact on receptor function 
during the luciferase reporter gene assay. 
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4.4 Verification of pCMX-GAL4-RXRb1/g-hinge-LBD fusion protein expression in 
COS-7 transfected cells  
COS-7 cells were transfected with the GAL4-DBD-RXRb1/g-hinge-LBD expression plasmids, 
and total protein staining along with Western blotting were performed to confirm transcription 
and synthesis of the fusion proteins. Lysed COS-7 cells were obtained 48-hours after seeding 
and 24 hours after pCMX-GAL4-RXRb1/g-hinge-LBD transfection. Two parallel 1 mm SDS-
PA gels were used for separation of the cell lysates using electrophoresis. To verify protein 
content and separation of the polypeptides, total protein staining with Coomassie Brilliant Blue 
was performed with one of the gels. Total protein staining indicated successful protein 
separation and approx. equal protein content distribution in each well (Fig 22). Gel number two 
was used for Western blotting. Through primary and secondary antibody probing, the synthesis 
of GAL4-DBD-RXRb1/g-hinge-LBD fusion proteins and b-actin (loading control) were 
assessed. The fusion proteins of GAL4-RXRg-hinge-LBD and GAL4-RXRb1-hinge-LBD 
migrated according to their predicted Mw, forming immunoreactive bands at 46kDa and 48kDa 
respectively. Only cells transfected with either gmRXRg-hinge-LBD or gmRXRb1-hinge-LBD 
produced bands at predicted sized for the two proteins, while b-actin (positive control) were 
observed in both transfected and non-transfected cells at 42kDa. This demonstrates that only 
transfected COS-7 cells expressed the desired fusion proteins.  
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Figure 22. Detection of expressed GAL4-RXRg-hinge-LBD and GAL4-RXRb1-hinge-LBD fusion proteins 
in transfected COS-7 cells. Western blotting was performed to verify synthesis of fusion protein in transfected 
COS-7 cells. Well A) is a non-transfected control; well B) is GAL4-DBD-RXRg-hinge-LBD transfected cells 
(46kDa); and well C) is GAL4-DBD-RXRb1-hinge-LBD transfected cells (48kDa). (1) Total protein staining of 
parallel SDS-PAGE gel using Coomassie Brilliant Blue. (2) PVDF-membrane treated first with 1:500 diluted 
mouse anti-GAL4 antibodies, and secondly with 1:2000 sheep anti-mouse-IgG. (3) b-actin (42kDa) revealed with 
1:1000 dilution of mouse anti-b-actin antibodies and 1:2000 sheep anti-mouse-IgG. SuperSignal ™ West Femto 




















4.5 Luciferase reporter gene assay  
Seeded COS-7 cells were then transfected with a plasmid mix consisting of either pCMX-
GAL4-RXRb1-hinge-LBD or pCMX-GAL4-RXRg-hinge-LBD, together with (mh100)x4tk 
luc (reporter plasmid) and pCMV-b-gal (normalization plasmid). The plasmid mix was 
prepared with a 1:10 plasmid mass ratio between pCMX-GAL4-RXRb1/g-hinge-LBD plasmids 
and the mh100)x4tk luc/pCMV-b-gal plasmids. After transfection, cells were exposed to serial 
diluted concentrations of 9-cis-RA, and the following OTCs: tributyltin chloride (TBT), 
tripropyltin chloride (TPT), fentin chloride (FC), fentin hydroxide (FH) and trimethyltin 
chloride (TMTC) (exposure concentrations: Table 53). After a 24-hour exposure period, the 
enzymatic activity of luciferase and b-galactosidase in COS-7 cell lysates were measured 
through luminescence and absorbance readings, respectively. b-galactosidase activity was used 
to normalize transfection efficiency between wells. The normalized luciferase activity was 
calculated as fold change in gmRXRb1/g activation compared to a baseline DMSO control. The 
assay was performed in triplicates three separate times, to produce an average fold activation.  
 
4.5.1 Ligand activation of gmRXRg-hinge-LBD and gmRXRb1-hinge-LBD 
9-cis-RA was used as a positive control for ligand activation of GAL4-RXRb1/g-hinge-LBD 
(from now on gmRXRb1/g), due to its presumed role as an endogenous natural ligand for the 
receptor. Accordingly, 9-cis-RA induced activation of gmRXRg and produced a maximum fold 
change in activation (Emax) of 58 at 20 µM (Fig 23). As no activation plateau was measured 
during 9-cis-RA exposure, no EC50 values were calculated. Notably, gmRXRb1 did not respond 
to the presence of 9-cis-RA and thus produced no significant increase (p<0.05) in fold change 
in a dose-response dependent manner (Fig 24).  
 
However, as the Western blot analyses (4.4) verified the synthesis of GAL4-DBD-RXRb1/g-
hinge-LBD fusion proteins in transfected CO7- cells, both proteins were further included in the 
assessment of the OTCs. The OTCs used were TBT, TPT, FC, FH and TMTC, representing a 
selection of OTCs that has been present in marine environments. COS-7 cells transfected with 
the gmRXRb1/g fusion proteins were exposed for 24 hours using the same dilution series for 




For gmRXRg, all OTC ligands produced significant (p<0.05) activation of the receptors apart 
from TMTC, where no significant activation occurred (Fig 23). TBT and TPT produced the 
maximum fold activation in luciferase activity of approx. 55 and 65 respectively at 0.1 µM. FC 
and FH had similar activation profiles with measured Emax of 33 and 31 at 0.1 µM respectively. 
The calculated EC50 and LOEC values further demonstrated a high potency of all OTCs in 
inducing transactivation of gmRXRg. TBT, FC and FH all indicated similar levels of potencies, 
however, TBT had slightly higher EC50 compared to FC and FH, at 0.006 µM, 0.0045 µM and 
0.0041 µM, respectively (Table 55). In contrast, the LOEC values for TBT were slightly higher 
than that of FC and FH, at 0.008 µM (0.004 µM for FC and FH). TPT was the least potent of 
the compounds tested with EC50 at 0.14 µM and LOEC at 0.02 µM. No EC50 values were 
calculated for TMTC as it did not induce transactivation of gmRXRg. In figure 23, the top 
concentration (0.5 µM) for all but TMTC, was removed due to cytotoxicity (see below). For 
gmRXRb1 (Fig 24), no activation was observed for any of the OTCs assessed. For TPT, FC 
and FH a slight decline in activation was observed. However, this is most likely due to cytotoxic 
effects observed in 4.5.3 and not an antagonistic effect on the receptor.  
 
 
Figure 23. Ligand activation of gmRXRg by 9-cis-RA, TBT, TPT, FH, FC, TMTC. Transfected COS-7 cells 
were exposed to the OTCs at identical concentrations. Each point represents gmRXRg activation through relative 
fold change in luciferase activity compared to DMSO (0.2-0.4%) exposed cells. The points are average activation 
of triplicate concentrations obtained from three separate and identical experiments, with standard error of mean 
(SEM). Points representing the highest concentration (0.5 µM) are removed from the graphs of TBT, TPT, FC and 
FH due to cytotoxicity. The dose-response curves were produced in GraphPad Prism 9. Statistical significance was 
calculated using Kruskal-Wallis test with Dunn´s multiple comparisons test and indicated with “*”: *=p≤0,05, 




Figure 24. Ligand activation of gmRXRb1 by 9-cis-RA, TBT, TPT, FH, FC, TMTC. Transfected COS-7 cells 
were exposed to the OTCs at identical concentrations. Each point represents gmRXRb1 activation through relative 
fold change in luciferase activity compared to DMSO (0.2-0.4%) exposed cells. The points are average activation 
of triplicate concentrations obtained from three separate and identical experiments, with standard error of mean 
(SEM). The dose-response curves were produced in GraphPad Prism 9. 
 
Table 55. LOEC, EC50, and Emax for gmRXRg activated by 9-cis-RA and OTCs. Values for LOEC (µM), EC50 
(µM) and Emax were calculated in GraphPad Prism 9. Statistical significance (p-value) of Emax was calculated using 
Kruskal-Wallis test with Dunn´s multiple comparisons test.  












gmRXRg 9-cis-RA 0.16 * 58 <0.001 
gmRXRg TBT 0.008 0.006 55 0.0081 
gmRXRg TPT 0.02 0.014 65 0.00275 
gmRXRg FC 0.004 0.0045 33 <0.001 
gmRXRg FH 0.004 0.0041 31 <0.001 
gmRXRg TMTC  - - - 





4.5.2 Assessing differences in RXR-LBD sequences     
To investigate possible reasons why the ligand activation profile of gmRXRg and gmRXRb1 
differed dramatically, the sequence similarity of their respective LBDs was examined in more 
detail. Amino acids constituting the LBD was selected and aligned for gmRXRa, gmRXRb1, 
gmRXRb2 and gmRXRg. Tsuji et al., (2015) and Billas et al., (2001) have previously reported 
13 amino acids involved in 9-cis-RA binding for RXR. In Figure 25, these 13 conserved amino 
acids were identified in the LBD sequences. Notably, a single difference in H3 was found 
between the gmRXR-LBDs. Here, an alanine (Ala236, gmRXRg) is exchanged for a threonine 
(Thr237) residue in gmRXRb1-LBD. A subsequent MSA was produced for the gmRXR-LBD 
isoforms along with obtained LBD sequences of RXR isoforms from D. rerio and H. sapiens 
(Fig 25). The same conserved alanine (Ala236, gmRXRg) residue was again observed to be 
conserved in all aligned sequences apart from gmRXRb1-LBD. Further, a cysteine group 
(Cys41) on the very C-terminal end of H10, reported to be involved in covalent binding and 
anchoring of the tin atom of OTCs to RXR-LBD, was conserved across all aligned sequences 
assessed (le Maire et al., 2009). In H7 of gmRXRb1 and gmRXRb2, a 14-residue insertion was 
observed. This insertion was in a region of high conservation across teleost and mammalian 
RXR isoforms. Notably, a subsequent MSA including the RXR isoforms d and e found in D. 
rerio, revealed that this insertion was shared by gmRXRb1, gmRXRb2, D. rerio RXRd, and 
RXRe (Fig 26). All 13 residues involved in 9-cis-RA binding, including the alanine residue 




Figure 25. Multiple sequence alignment of gmRXRa, gmRXRb1, gmRXRb2 and gmRXRg LBDs. The MSA 
shows aligned LBD sequences from the different gmRXR isoforms. Conserved amino acids involved in 9-cis-RA 
binding are indicated as red residues. None-conserved amino acids involved in 9-cis-RA binding are indicated 
with green residues. The “*” over Cys217 (gmRXRb1) represents a residue involved in anchoring OTCs during 
RXR binding. Helices 1, 3-12 are represented with grey lines and are numbered H1, H3, H4, etc. MSA produced 




Figure 26. Multiple sequence alignment of LBD sequences from gmRXRa, gmRXRb1, gmRXRb2, 
gmRXRg, drRXRe and drRXRd. The MSA of the LBDs of gmRXR isoforms and D. rerio RXRe and RXRd 
(drRXRe and drRXRd). A 14-residue insert located on gmRXR in H7, marked in red, is conserved between 
gmRXRb1, gmRXRb2, drRXRe and drRXRd. Further, the alanine residue (Ala236, gmRXRg) is still conserved 
for all but gmRXRb1 (green). Alignment produced in Clustal Omega and visualized in JalView. The percentage 
amino acid identity is colored in blue.  
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4.5.3 Cytotoxicity and cell viability  
To investigate the possible cytotoxic effects of 9-cis-RA and the OTCs used in the luciferase 
reporter gene assay, a COS-7 cell viability assay was done parallel to the Luciferase reporter 
gene assay. gmRXRb1/g transfected COS-7 cells were exposed to 9-cis-RA at concentrations 
of 20 µM, 4 µM and 0.8 µM, while the OTCs were exposed at 0.5 µM, 0.1 µM and 0,02 µM, 
thus representing the three highest concentrations used in the luciferase reporter gene assay. 
Triton X-100 (0.5 µM) was used as positive control for cytotoxicity. Exposures for all 
compounds were over a 24-hour period, identical to exposure regime used in the luciferase 
reporter gene assay. A significant decrease (p<0.05) in membrane permeability (CFDA-AM) 
was observed at 0.5 µM for FC and FH, while a significant decrease (p<0.05) in metabolic 
activity (rezasurin) was observed for TBT, FC, FH and TPT at 0.5µM (Fig 27).  
 
Figure 27. Changes in COS-7 cell viability after ligand exposure. Transfected COS-7 cells were exposed to the 
three highest concentrations of 9-cis-RA, TBT, TPT, FC, FH and TMTC, used in luciferase reporter gene assay. 
Triton X-100 was used as positive control of cytotoxicity. Exposure to DMEM with 0.5% DMSO was used as 
solvent control and is illustrated as stippled line. Rounded dots represent change in membrane permeability 
(CFDA-AM) and squares represent change in metabolic activity (rezasurin). Statistical significance was calculated 
using Kruskal-Wallis test with Dunn´s multiple comparisons test in GraphPad Prism 9 and indicated with “*”: 
*=p≤0,05, **=p≤0,01 and ***=p≤0,001.  
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5. Discussion  
This thesis has focused on identifying and characterizing the different isoforms of RXR in 
Atlantic cod (gmRXR) regarding their primary structure, phylogeny, tissue-specific expression, 
and interactions with endogenous and exogenous ligands. RXR in other species have been 
observed to be activated by 9-cis-RA, the proposed natural endogenous ligand of RXR. OTCs 
represent a highly toxic group of environmental pollutants capable of causing endocrine 
disruption through RXR-biding in both terrestrial and marine environments. OTCs have 
previously been observed to have particularly detrimental effects on marine environments, as 
their half-life is significantly prolonged here compared to terrestrial environments. Thus, 
assessing the potential of OTCs to bind and transactivate gmRXR isoforms, may provide further 
insights into the adverse effects these compounds may have on Atlantic cod and marine teleosts 
in general.  
 
5.1 Evolution, localization and characterization of gmRXR isoforms 
RXR isoforms and their abilities to associate to and regulate the function of several different 
NRs across phyla, have made them key figures within the fields of molecular endocrinology 
and toxicology. RXR-encoding genes have been revealed in all vertebrates, including 
identification of RXR homologues in some of the oldest metazoan lifeforms, such as Porifera 
(Wiens et al., 2003). In this study, four paralogous RXR genes were identified in the Atlantic 
cod genome and shown to group phylogenetically with RXR homologs from other Gadiformes 
species. The gmRXRs were further phylogenetically clustered together with other teleost RXR 
isoforms (i.e., RXRa1, RXRb1, RXRb2 and RXRg1), allowing the four Atlantic cod RXR 
proteins to be classified as gmRXRa, gmRXRb1, gmRXRb2 and gmRXRg. Of these gmRXR 
isoforms, gmRXRb2 homologs were only identified in other teleosts. In fact, genes encoding 
NRs have in general been identified in larger numbers in teleosts compared to mammalian 
species. In Atlantic cod, 72 NR-encoding genes have been identified, while only 48 NR genes 
are found in humans (Eide et al., 2018). However, the diversity in presence and numbers of NR 
isoforms in teleost species seem to vary substantially throughout evolution. In fact, genome 
mining performed of RXR in D. rerio, S. salar and Atlantic cod, was in this study found to 
possess genes encoding six, five and four RXR proteins, respectively. Two initial whole 
genome duplication (WGD) events in early vertebrate evolution, followed by a third teleost 
specific WGD event (Meyer & Van de Peer, 2005), along with other evolutionary events, 
including neo- and subfunctionalization, gene loss, and chromosomal inversions, are suggested 
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to explain how both number and presence of NR isoforms are substantially different between 
teleost species (Sandve et al., 2018). Through WGD events, a single RXR gene might evolve 
to encode functionally diverse proteins (i.e., RXRa, RXRb and RXRg) through deletion, 
insertion or substitution of nucleotides. With additional teleost specific WGD events giving rise 
to new isoforms, such as RXRa1, RXRb1, RXRb2, RXRg1, RXRd and RXRe. Further, 
observed 9-cis-RA binding in some of the most primitive Cnidarian species, such as Tripedalia 
cystophora, indicates an early gain of function in ligand-binding from an evolutionary 
perspective (Groot et al., 2006). Interestingly, reports of RXR homologues in arthropods unable 
to bind 9-cis-RA may suggest a secondary loss of ligand binding capacity during metazoan 
evolution (Fonseca et al., 2020). However, some arthropod orthologues of RXR, called 
ultraspiracle protein (USP), in species such as Locusta migratoria have proven to bind 9-cis-
RA at high affinities (Fonseca et al., 2020). Thus, a more comprehensive and detailed 
phylogenetic study is needed to produce a map covering episodes of gain and loss in function 
when regarding 9-cis-RA binding to RXR.  
 
The gmRXRa, gmRXRb1, gmRXRb2 and gmRXRg isoforms identified in the Atlantic cod 
genome in this study were encoded from separate genes located on chromosome 19, 6, 22 and 
12, respectively. Complete DNA-sequences of these genes were obtained, and the amino acid 
sequences were deduced. This allowed the annotation of exonic and intronic sequences, and 
further the annotation of the DBDs, the hinge-regions, the LBDs, and identification of residues 
previously shown to be involved in 9-cis-RA ligand biding in other species. The gmRXR 
encoding genes translate into proteins that slightly vary in size, gmRXRb1 being the smallest 
at 50kDa, and gmRXRa the largest at 63kDa. gmRXRb1, gmRXRb2 and gmRXRg share 
similar sizes as RXR proteins in other species, which typically range between 50-55kDa 
(Feldman et al., 2008). In contrast, the gmRXRa is relatively large when compared to H. 
sapiens RXRa and the two RXRa isoforms (RXRa1 and RXRa2) in D. rerio´s, which are 
50kDa, 46kDa and 47kDa, respectively. This is due to an observed extended N-terminal of 
gmRXRa. This extension is reoccurring and seemingly unique to RXRa of some other 
examined teleost species, including E. lucius, S. salar and Cyprinus carpio. To which extent 
this elongation of the N-terminal might affect receptor function is however not known. Protein 
sequence alignment of the different functional domains of gmRXR isoforms, indicated 
extensive conservation of the DBD. Comparison of the DBDs in the gmRXR isoforms 
compared with corresponding isoforms from H. sapiens and D. rerio demonstrated sequence 
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similarities exceeding 80%, while the LBD was moderately conserved comparatively at 56% 
sequence similarity. These functional domains are generally well conserved in NRs as they 
determine the NRs ability to bind DNA and ligands as well as their ability to associate with 
partner NRs or other proteins (heat-shock proteins, p-proteins, co-activators, etc.). Interestingly, 
the area of the DBD sequence that demonstrated the highest level of variability among both the 
gmRXR isoforms and other species was the T-box. Both hetero- and homodimeric complexes 
of RXR extensively use the T-box when mediating protein-protein interactions with the 
upstream zinc-finger (II) modular region (Dawson & Xia, 2012). This region of RXR has been 
observed in other species to be able to undergo conformational changes to accommodate 
binding of both RXR homo- and heterodimers  (Rastinejad et al., 2000). This degree of 
structural freedom in the gmRXR-T-box may suggest a similar ability of Atlantic cod isoforms 
to form functional complexes with a variety of different partner NRs and other proteins. Further, 
there were some key differences in the LBD structures related to ligand binding properties that 
will be discussed later (5.3.2).  
 
5.2 Tissue specific expression of gmRXR isoforms   
The eleven tissues obtained from juvenile female Atlantic cod (i.e., ovary, muscle, head-kidney, 
skin, spleen, heart, stomach, liver, brain, gill and eye), were used to produce comprehensive 
tissue specific expression profiles for gmrxra, gmrxrb1, gmrxrb2 and gmrxrg. From these 
analyses, gmrxrb1 was observed to be the most abundant and widely expressed isoform in all 
tissues. Particularly high levels of gmrxrb1 transcripts were measured in ovary and head-
kidney, with lowest levels measured in muscle tissues. gmrxrb2 and gmrxrg were relatively 
ubiquitously expressed with high levels of gmrxrb2 transcripts measured in brain and stomach, 
and gmrxrg transcripts measured at high levels in liver and muscle. gmrxra was by far the least 
expressed of the gmRXR isoforms in all tissues examined. Interestingly, tissue specific profiles 
of H. sapiens RXR isoforms have provided evidence that rxra is particularly abundant in 
testis/ovaries, liver and kidney (Uhlén et al., 2015). However, when comparing expression 
profiles of gmrxra and gmrxrb1 in ovary tissue, gmrxrb1 transcript was measured at levels 118 
times higher than that of gmrxra. Further, when comparing of the most abundant gmRXR 
isoforms in liver tissue (i.e., gmrxrb1 and gmrxrg)  to gmrxra, the transcripts for gmrxrb1 and 
gmrxrg  were measured to be ~76 and ~56 times higher than that of gmrxra. Interestingly, He 
et al (2009) reported the tissue specific profiles of RXR isoforms (smRXRa, smRXRb and 
smRXRg) in the marine teleost Sebastiscus marmiratus. When comparing gmRXR tissue 
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specific expression to RXR expression in S. marmiratus, several similarities were observed. 
Here, smrxrb was, like gmrxrb1, most widely abundant isoform in overall tissue expression, 
followed by smrxrg, with smrxra measured to be the least abundant. Further, smrxrb and smrxrg 
expression levels in ovary and liver tissues in S.marmiratus, were observed to be similar to that 
of gmrxrb1 and smrxrg in corresponding tissues in Atlantic cod. Unfortunately, further 
comparisons of tissue specific expression in other fish are difficult as data of other teleost 
species is scarce, with studies performed mostly with regards to tissue expression of RXR in 
embryonal or larval stages. However, with the apparent similarities in RXR expression profiles 
between Atlantic cod and S. marmiratus, and the disagreement in RXR expression profiles 
when comparing Atlantic cod and H. sapiens, it may suggest that Atlantic cod, and teleost 
species alike, have different functional roles compared to that of mammalian RXR. Thus, it can 
be suggested that a neofunctionalization of gmRXRb1 and a subfunctionalization of gmRXRa, 
have occurred during Atlantic cod evolution, although more studies are needed to confirm this 
hypothesis. Further, the high expression levels of gmrxrb1 and smrxrb in Atlantic cod and S. 
marmiratus ovary, respectively, suggest an active role in sexual maturation, development, 
and/or fertility. In fact, based on embryonic expression patterns of RXRb in D. rerio, Waxman 
& Yelon (2007) suggested that RXRb isotypes and isoforms are the only RXRs mediating 
heterodimeric interactions with hormone receptors during development in both teleost fishes 
and mammals (Waxman & Yelon, 2007). This is supported by observations where only RXRb 
null mice resulted in approx. 50% death before or at birth, with the remaining mutants alive 
being sterile (Krezel et al., 1996). However, to my knowledge, no knockout studies of RXR 
isoforms in teleost species have been performed, but it should be done to assess the importance 
and involvement of specific teleost RXR isoforms during fish development. Further, Atlantic 
cod gmrxrb1 and gmrxrg, as well as S. marmiratus smrxrb and smrxrg, were measured to be 
abundant in liver-tissue, indicating an involvement of these RXR isoforms in recognizing 
xenobiotics and mediating a response as a dimeric partner. However, with the reported the loss 
of PXR in Atlantic cod (Eide et al., 2018), it may suggest that gmRXRb1/g have a different 
mechanism of action when mediating a responses to xenobiotic exposure. In mammals the 
RXR:PXR heterodimer is suggested to promote cyp3a4 expression as a response to numerous 
different xenobiotic exposures (Yuan et al., 2020). Thus, identifying the response mechanism 
and possible alternative heterodimeric partners of gmRXRb1/g during xenobiotic exposure, 
would be useful in expanding our understanding of how Atlantic cod, and related teleost 
species, are affected by and respond to environmental pollutants.  
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5.3 Ligand induced activation of gmRXRb1 and gmRXRg  
Due to time constraints, ligand induced activation assessment of gmRXRs isoforms was 
performed solely using gmRXRb1 and gmRXRg. gmRXRb1 and gmRXRg was chosen based 
on their high levels of expression in liver tissue, as the liver is prone to interact with most 
xenobiotics that enter the organism and has a major role in handling such compounds. In this 
thesis, a GAL4-UAS based luciferase reporter gene assay was established and used for 
obtaining ligand-activation profiles for gmRXRb1 and gmRXRg. Some advantages using the 
GAL4-UAS based system include: (1) The UAS results in downstream gene expression at 
higher levels than that of endogenous tissue-specific promoters, and thus increase sensitivities 
(Yamada et al., 2020). (2) The use of an exogenous promoter from yeast (UAS) will minimize 
the potential interference of endogenous components present in the cell line used for the assay 
(Yamada et al., 2020). (3) With GAL4-UAS, transactivation of NR is un-affected by the 
absence of dimerization partners (Zarifi et al., 2012). In this assay, the expression of the reporter 
genes is directly correlated to transactivation of the NR in question and can be measured 
through luminescence (produced by luciferase). This allows comparisons of activation profiles 
induced by ligand exposure, as well as analyzing ligand potency and efficacy over varying 
concentrations.  
 
5.3.1 Assessing ligand activation profiles of gmRXRb1 and gmRXRg  
COS-7 cells were transfected with the plasmids pCMX-GAL4-gmRXRb1-hinge-LBD and 
pCMX-GAL4-gmRXRg-hinge-LBD, and subsequently exposed to 9-cis-RA. 9-cis-RA was 
used as a control ligand (agonist) due to this compound being the most widely used endogenous 
ligand within RXR research. Although not regarded as a bona fide natural endogenous ligand, 
high affinity binding of 9-cis-RA to RXR has been reported in a plethora of evolutionary 
linages, such as vertebrates, annelids and mollusks. Based on these factors, transactivation of 
both gmRXRb1 and gmRXRg induced by 9-cis-RA exposure was expected. Accordingly, 9-
cis-RA exposure of gmRXRg produced a clear dose-response. Initial testing started with a 
maximum concentration of 1 µM 9-cis-RA and subsequently increased in new experiments as 
no clear plateau of activation was observed. However, increasing maximum concentrations 
from 1 µM to 20 µM, still did not to produce a plateau. In previous studies using different cell 
lines such as JEG-3 cells, COS-1 cells, HepG2 cells and Caco-2 cells, it was reported a 
maximum 9-cis-RA-mediated activation of RXR at 1µM (JEG-3 and COS-1) and 10µM 
(HepG2 and Caco-2) (Nakanishi et al., 2005; Fonseca et al., 2020; Wang et al., 2008). Backlund 
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& Ingelman-Sundberg (2005) observed that ligand activation of another transcription factor, 
the aryl hydrocarbon receptor (AHR), fluctuated between cell lines when a GAL4-DBD-AHR 
system was used. Thus, in future studies it might be worth investigating different cell lines when 
assessing 9-cis-RA-induced RXR transactivation. Surprisingly, no dose-response was 
measured during 9-cis-RA exposure of COS-7 cells transfected with gmRXRb1, at any 
concentrations tested. As a result of this, possibilities that transfected COS-7 cells did not 
transcribe, nor synthesize the functional GAL4-RXRb1-hinge-LBD fusion proteins were 
considered. However, western blotting confirmed synthesis of the fusion proteins in transfected 
COS-7 cells, with immunoreactive bands forming at expected Mw for both GAL4-RXRb1-
hinge-LBD and GAL4-RXRg-hinge-LBD. Thus, the possibility of gmRXRb1 being 
unresponsive to 9-cis-RA was accepted, and subsequent assessment of gmRXRg and 
gmRXRb1 activation after exposure to OTCs was performed. 
 
OTCs have long been associated with RXR as an agonistic xenobiotic ligand, with compounds 
such as TBT observed to induce imposex in marine gastropods and masculinization of D. rerio 
as a result of disruption of the RXR signaling pathway (Gooding Lassiter et al., 2003). TBT 
along with TPT, FC and FH are potent active agents found in pesticides (i.e., fungicides, 
molluscicides, insecticides, etc.) that previously were used in marine antifoulants and observed 
to bioaccumulate in marine species (Demehin et al., 2017). Over the past two decades, these 
compounds have globally been banned from commercial use and environmental concentrations 
are slowly decreasing (Schøyen et al., 2019), although illegal production and use is still found 
around some parts of Africa and east-Asia. TMTC is one of the few chemicals in the OTC 
family that does not originate exclusively from an anthropogenic origin. Although not 
previously observed as an RXR agonist, TMTCs unique ability to form naturally in the 
environment made it interesting to include in the present study. Although the agonistic 
relationship between OTCs and RXR have been reported previously, no information is available 
considering their effect on RXR from Atlantic cod. Thus, the chemicals mentioned above were 
chosen when assessing the potential ability of OTCs to transactivate gmRXRg and gmRXRb1. 
gmRXRg was activated by TBT, TPT, FC and FH. Both TBT and TPT produced the highest 
fold change in activation profile, with Emax of 55 and 65 respectively. Consistent with previous 
observations, TMTC did not act in an agonistic manner (Nakanishi et al., 2005). Notably, TBT, 
TPT, FC and FH all achieved relatively high efficacies (Emax) at low concentrations (0.1 µM) 
compared to 9-cis-RA, where far higher concentrations where needed to produce a similar 
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response. Even in studies utilizing other cell lines, considerably higher concentrations of 9-cis-
RA is still needed to induce transactivation of the receptors, compared to the concentrations 
used for OTCs in the present study. This suggests that gmRXRg has a higher activation potential 
when binding OTCs compared to the proposed endogenous ligand. Further, the high Emax 
values, paired with the low EC50 -and LOEC values produced by these OTCs at low 
concentrations, indicates high potency and efficacy in inducing transactivation of RXR in 
Atlantic cod. Similarly, TBT exposure studies on gastropods indicates the ability of these 
compounds to produce adverse health effects at low concentrations. Gooding et al (2003) 
observed TBT induced imposex of Ilyanassa obsoleta at concentrations as low as 1ng/L, with 
Abidli et al (2009) observing TBT-induced imposex of Gastropoda muricidae at 5ng/L. 
Moreover, recent studies reported high concentrations of accumulated fentin in teleost liver 
tissue (1000-3500 ng/g ww), suggesting that teleosts may not be able to effectively metabolize 
these compounds (Sham et al., 2021). Thus, considering the observed potency of OTCs to 
transactivate gmRXRg in Atlantic cod, and previous studies indicating low rates of OTC 
degradation in teleost liver, as well as OTC-induced imposex at low concentrations in 
gastropods, it is reason to suggest that OTCs are still an imminent threat to marine species, even 
though environmental concentrations are decreasing. However, more data from long term 
exposures of OTCs on teleost species is needed to further investigate the potential adverse 
effects such compounds produce at low (ng) concentrations. Notably, and as observed with 9-












5.3.2 Differences in gmRXRg-LBD and gmRXRb1-LBD that may affect ligand binding  
The dramatic differences in activation profiles for gmRXRg and gmRXRb1 after exposure to 
both 9-cis-RA and OTCs, prompted a more thorough assessment of their LBDs. This was done 
to assess for differences in the amino acid sequence, which in turn might manifest as the 
inability of gmRXRb1 to bind and be activated by 9-cis-RA and OTCs. When inspecting the 
LBD alignments for gmRXRa1, gmRXRb1, gmRXRb2 and gmRXRg, a conserved region of 
14 residues in H7 for both gmRXRb1 and gmRXRb2 was observed. Interestingly, a similar 
insertion is found in RXRd-LBD and RXRe-LBD of D. rerio (B. Jones et al., 1995). D. rerio 
RXRd and RXRe are believed to have evolved separately after a common ancestor branched 
off the RXR family, and 9-cis-RA was observed to not induce transactivation of these two 
isoforms (B. Jones et al., 1995; Philip et al., 2012). These RXR isoforms have further been 
observed unaffected by ATRA, 11-cis-RA, 13-cis-RA and retinol exposure (Seo et al., 2002). 
Moreover, these RXR isoforms are therefore believed to be activated through other interactions 
than ligand binding. For both gmRXRb1 and gmRXRb2, as well as D. rerio RXRd and RXRe, 
the additional stretch of amino acids is located at regions with relatively well conserved amino 
acid sequences on both sides of this insertion. X-ray crystallography studies of this conserved 
region in D. rerio suggested that this region constitute important parts of the ligand binding 
pocket (LBP)(B. Jones et al., 1995). Thus, it is hypothesized that the insert in D. rerio RXRd-
LBD and RXRe-LBD causes structural differences to the LBP and inhibit 9-cis-RA binding 
along with other ligands, both endogenous and exogenous. Although gmRXR crystallography 
data is not available, given the close sequence similarity between gmRXRs and D. rerio RXRs, 
it is not unlikely that the 14 amino acid extension in the gmRXRb1 LBD produces similar 
changes to the LBP structure and subsequent function. With X-ray crystallography and/or 
docking simulations, such data can be derived. If in fact this insertion proves to alter the LBP 
structure in gmRXRb1, it may suggest that this gmRXR isoform has different properties than 
that of H. sapiens RXRb and D. rerio RXRb, as these are able to bind both 9-cis-RA and OTCs. 
One possibility is that gmRXRb1 strictly functions as a non-permissive heterodimer with no 
synergistic activation mediated by ligand binding to both dimeric partners. Here, gmRXRb1 
would only be transactivated through interacting with a ligand-bound partner NR (i.e., PXR, 
RAR, VDR, etc.). This may further suggest that gmRXRb1 regulates transcription in a strictly 
heterodimeric fashion, unable to form functional homodimeric configurations. However, with 
the high gmRXRb1 abundance in most juvenile Atlantic cod tissues, it is likely that this isoform 
 74 
is involved in regulation of a vast array of physiological processes in numerous cell types, 
possibly through interactions with several NRs. Thus, even if gmRXRb1 is structurally 
inhibited from being activated by the tested compounds, it may still play an important role as a 
transcriptional regulator in multiple tissues of, as an obligate non-permissive heterodimer.    
 
Further, 13 amino acid residues were identified in the LBD, representing key residues in binding 
to 9-cis-RA in other species (Billas et al., 2001). These residues were conserved in the gmRXR 
isoforms, as well as in H. sapiens RXRa, RXRb, and RXRg, and in D. rerio RXRa1, RXRb1, 
RXRb2 and RXRg. However, of these 13 residues, a single amino acid difference was found in 
gmRXRb1. Here, the conserved alanine (e.g., Ala236, gmRXRg) residue was exchanged for a 
threonine (Thr237, gmRXRb1). These residues are apparently located on H3, which has been 
observed to undergo conformational changes to accommodate and stabilize co-activator 
binding. Upon ligand biding to H. sapiens RXRa, H3 undergoes a 13Å tilt allowing it to interact 
with H4 and H12. In this configuration, a surface structure is created between H3, H4 and H12, 
uncovering NR-box motifs and enabling co-activator and co-repressor binding (Dawson & Xia, 
2012). The binding of co-activators further facilitates recruitment of other regulatory proteins. 
One set of these regulatory proteins may consist of transcriptional protein complexes which 
recognize and place the RXR-complex at the transcriptional start site. Apart from co-activator 
binding, the interaction between H3 and H12 is especially important as H12 contains the AF-2 
domain, involved in transcriptional regulation. Through H3 interactions with AF-2, H3 is 
suggested to act as a conduit in stabilizing homo-and heterodimeric interactions, along with 
being a binding site for regulatory proteins (Kojetin et al., 2015). Thus, it is suggested that the 
residue substitution of Ala236 (gmRXRg) to Thr237 (gmRXRb1) might affect co-activator and 
regulatory protein binding to gmRXRb1. To what extent this may result in an altered ligand 
binding profile remains to be elucidated. To assess the possibility that the residue substitution 
observed in gmRXRb1-H3 may affect ligand binding, in vitro mutagenesis studies should be 








5.4 Conclusion  
In this study four isoforms of the homo- and heterodimeric NR partner, RXR, involved in major 
cellular pathways such as development, metabolism and homeostasis, were identified in the 
Atlantic cod genome. These RXR isoforms were further characterized regarding their primary 
structure, tissue specific expression, and phylogeny. The four gmRXR isoforms included 
gmRXRa, gmRXRb1, gmRXRb2 and gmRXRg. Based on tissue specific expression profiles, 
gmRXRb1 and gmRXRg were cloned from Atlantic cod liver, and the effects of 9-cis-RA and 
OTCs on receptor activation was assessed by establishing a luciferase-based reporter gene 
assay. gmRXRb1 and gmRXRg demonstrated significant deviations in activation profiles. Here, 
gmRXRg was potently activated by both the presumed natural endogenous ligand (9-cis-RA) 
and all OTCs (TBT, TPT, FC, FH) assessed, apart from TMTC. On the other hand, gmRXRb1 
showed no response to any of the ligands after exposure. Subsequent findings of a 14 amino 
acid insert in gmRXRb1-LBD, along with a single substitution in conserved amino acids 
involved in 9-cis-RA binding (Ala237 to a Thr237), were suggested as possible reasons for the 
lack of gmRXRb1 activation. As a result of this, along with the tissue specific expression 
profiles, it is suggested that gmRXRb1 may have undergone neofunctionalization during 
Atlantic cod evolution, manifesting as transcriptional regulation in different cells and tissues 
through obligate non-permissive heterodimeric interactions with other NRs. In contrast, 
gmRXRg is believed to maintain similar functional roles as observed in previous studies from 
e.g., H. sapiens RXR and D. rerio RXR, being a NR capable of inducing transcriptional 
regulation when bound by a ligand, likely through both homo- and heterodimeric interactions. 
Nevertheless, the high potency and efficacy of OTCs in inducing gmRXRg transactivation, 
along with previous published studies, indicate the ability of OTCs to produce adverse health 
effects through disruption of RXR signaling at low concentrations in Atlantic cod.  It is 
therefore suggested that these compounds are still a major threat to the wellbeing of marine 








5.5 Future perspectives  
In this study a lot of new information regarding gmRXR isoforms was produced. However, the 
limited numbers of previous studies involving RXR isoforms in Atlantic cod, or teleosts in 
general, left a desire for more. Firstly, a more thorough and comprehensive phylogenetic 
mapping of gmRXR, and other cold-water teleost RXRs, should be performed. This could be 
used as a tool to uncover potential episodes of primary and secondary loss and gain in ligand 
binding function, throughout RXR evolution. Further, continuing the functional 
characterization of Atlantic cod gmRXR, and other NRs, is important to continue to observe 
the effects environmental pollutants may have on Atlantic cod.  
 
In this study, a UAS/GAL4 based reporter gene assay was established with gmRXRb1 and 
gmRXRg. This could be used for further assessments of other potential exogenous compounds 
ability to transactivate the gmRXRs. With the characterization of gmRXRa and gmRXRb2 in 
this study, these isoforms could also be cloned and included into a reporter gene assay, to further 
assess possible similarities and differences in ligand binding profiles for all the gmRXR 
isoforms. However, as the GAL4-UAS system used in this study is cell-dependent, it would be 
interesting to see if a cell-independent assay would produce more representative studies. The 
AlphaLisa assay is one potential way to assess cell-independent ligand activation of gmRXR 
isoforms, and other NRs in general. Recombinant expression, protein purification, and X-ray 
crystallography, along with 9-cis-RA docking simulations, could further provide important 
insight in how the isoforms might differ structurally and how this may affect ligand binding of 
different environmental pollutants.  
 
Continuing, a mutagenesis assay of gmRXRb1 where the inserted Thr237 is mutated to the 
conserved Ala-residue, found in all other examined RXR isoforms, would also be interesting. 
This would provide insight in whether this alteration in sequence is manifested as an inability 
to bind ligand(s). A mutagenesis study should also be performed to remove the 14 amino acids 
insert in gmRXRb1 and gmRXRb2, to assess its potential role in inhibiting ligand binding. 
Chromatin immunoprecipitation (ChIP) assays could also be utilized to assess the hypothesis 
proposed of gmRXRb1 as an obligate non-permissive heterodimer through examining target 
genes for the isoform. However, for ChIP, development and production of gmRXR specific 
antibodies are required.   
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Furthermore, to assess the involvement of the gmRXR isoforms involvement in development 
and xenobiotic response, a larger tissues sample pool from different Atlantic cod individuals at 
different developmental stages would be useful. By utilizing tissue samples from a larger 
number of individuals, both juveniles and adults, and of both sexes, a more complete and 
reliable profile of tissue specific gmrxr expression could be produced. Using in situ 
hybridization, the expression of the isoforms during embryonic and larval stages could be 
performed, while tissue or cell-culture exposure would allow investigating of adult individuals 






































Ahuja, H. S., Szanto, A., Nagy, L., & Davies, P. (2003). The retinoid X receptor and its 
ligands: Versatile regulators of metabolic function, cell differentiation and cell death. 
Journal of biological regulators and homeostatic agents, 17, 29–45. 
Aranda, A., & Pascual, A. (2001). Nuclear hormone receptors and gene expression. 
Physiological Reviews, 81(3), 1269–1304. 
https://doi.org/10.1152/physrev.2001.81.3.1269 
Ashraf, M. A. (2017). Persistent organic pollutants (POPs): A global issue, a global challenge. 
Environmental Science and Pollution Research, 24(5), 4223–4227. 
https://doi.org/10.1007/s11356-015-5225-9 
Berg, P. R., Star, B., Pampoulie, C., Sodeland, M., Barth, J. M. I., Knutsen, H., Jakobsen, K. 
S., & Jentoft, S. (2016). Three chromosomal rearrangements promote genomic 
divergence between migratory and stationary ecotypes of Atlantic cod. Scientific 
Reports, 6(1), 23246. https://doi.org/10.1038/srep23246 
Billas, IsabelleM. L., Moulinier, L., Rochel, N., & Moras, D. (2001). Crystal Structure of the 
Ligand-binding Domain of the Ultraspiracle Protein USP, the Ortholog of Retinoid X 
Receptors in Insects. Journal of Biological Chemistry, 276(10), 7465–7474. 
https://doi.org/10.1074/jbc.M008926200 
Castillo, A. I., Sánchez-Martínez, R., Moreno, J. L., Martínez-Iglesias, O. A., Palacios, D., & 
Aranda, A. (2004). A Permissive Retinoid X Receptor/Thyroid Hormone Receptor 
Heterodimer Allows Stimulation of Prolactin Gene Transcription by Thyroid Hormone 
and 9-cis-Retinoic Acid. Molecular and Cellular Biology, 24(2), 502–513. 
https://doi.org/10.1128/MCB.24.2.502-513.2004 
Cheshenko, K., Pakdel, F., Segner, H., Kah, O., & Eggen, R. I. L. (2008). Interference of 
endocrine disrupting chemicals with aromatase CYP19 expression or activity, and 
consequences for reproduction of teleost fish. General and Comparative 
Endocrinology, 155(1), 31–62. https://doi.org/10.1016/j.ygcen.2007.03.005 
Cruz, A., Anselmo, A. M., Suzuki, S., & Mendo, S. (2015). Tributyltin (TBT): A Review on 
Microbial Resistance and Degradation. Critical Reviews in Environmental Science and 
Technology, 45(9), 970–1006. https://doi.org/10.1080/10643389.2014.924181 
Dawson, M. I., & Xia, Z. (2012). The Retinoid X Receptors and Their Ligands. Biochimica et 
biophysica acta, 1821(1), 21–56. https://doi.org/10.1016/j.bbalip.2011.09.014 
Delfosse, V., Huet, T., Harrus, D., Granell, M., Bourguet, M., Gardia-Parège, C., Chiavarina, 
B., Grimaldi, M., Mével, S. L., Blanc, P., Huang, D., Gruszczyk, J., Demeneix, B., 
Cianférani, S., Fini, J.-B., Balaguer, P., & Bourguet, W. (2021). Mechanistic insights 
into the synergistic activation of the RXR–PXR heterodimer by endocrine disruptor 
mixtures. Proceedings of the National Academy of Sciences, 118(1). 
https://doi.org/10.1073/pnas.2020551118 
Demehin, A. I., Babajide, J. O., & Salihu, S. O. (2017). The Environmental Persistence of 
Organotin Compounds. 10. 
Doherty, J. D., & Irwin, W. A. (2011). Chapter 49—Organotins (tributyltin and triphenyltin). 
I R. C. Gupta (Red.), Reproductive and Developmental Toxicology (s. 657–672). 
Academic Press. https://doi.org/10.1016/B978-0-12-382032-7.10049-9 
 79 
Dowhan, D. H., & Muscat, G. E. (1996). Characterization of the AB (AF-1) region in the 
muscle-specific retinoid X receptor-gamma: Evidence that the AF-1 region functions 
in a cell-specific manner. Nucleic Acids Research, 24(2), 264–271. 
Egea, P. F., Mitschler, A., Rochel, N., Ruff, M., Chambon, P., & Moras, D. (2000). Crystal 
structure of the human RXRα ligand-binding domain bound to its natural ligand: 9-cis 
retinoic acid. The EMBO Journal, 19(11), 2592–2601. 
https://doi.org/10.1093/emboj/19.11.2592 
Eide, M., Rydbeck, H., Tørresen, O. K., Lille-Langøy, R., Puntervoll, P., Goldstone, J. V., 
Jakobsen, K. S., Stegeman, J., Goksøyr, A., & Karlsen, O. A. (2018). Independent 
losses of a xenobiotic receptor across teleost evolution. Scientific Reports, 8(1), 10404. 
https://doi.org/10.1038/s41598-018-28498-4 
Evans, R. M., & Mangelsdorf, D. J. (2014). Nuclear Receptors, RXR & the Big Bang. Cell, 
157(1), 255–266. https://doi.org/10.1016/j.cell.2014.03.012 
Feldman, D., Malloy, P. J., Krishnan, A. V., & Balint, E. (2008). CHAPTER 13 - Vitamin D: 
Biology, Action, and Clinical Implications. I R. Marcus, D. Feldman, D. A. Nelson, & 
C. J. Rosen (Red.), Osteoporosis (Third Edition) (s. 317–382). Academic Press. 
https://doi.org/10.1016/B978-012370544-0.50015-X 
Fonseca, E., Ruivo, R., Borges, D., Franco, J., Santos, M., & Castro, L. (2020). Of Retinoids 
and Organotins: The Evolution of the Retinoid X Receptor in Metazoa. Biomolecules, 
10, 594. https://doi.org/10.3390/biom10040594 
Fodor, I., Urbán, P., Scott, A. P., & Pirger, Z. (2020). A critical evaluation of some of the recent 
so-called ‘evidence’ for the involvement of vertebrate-type sex steroids in the 
reproduction of mollusks. Molecular and Cellular Endocrinology, 516, 110949. 
https://doi.org/10.1016/j.mce.2020.110949 
Gampe, R. T., Montana, V. G., Lambert, M. H., Wisely, G. B., Milburn, M. V., & Xu, H. E. 
(2000). Structural basis for autorepression of retinoid X receptor by tetramer 
formation and the AF-2 helix. Genes & Development, 14(17), 2229–2241. 
Garrod, D. (2011). Population Dynamics of the Arcto-Norwegian Cod. Journal of the 
Fisheries Research Board of Canada, 24, 145–190. https://doi.org/10.1139/f67-012 
Gooding Lassiter, M., Wilson, V., Folmar, L., Marcovich, D., & Leblanc, G. (2003). The 
Biocide Tributyltin Reduces the Accumulation of Testosterone as Fatty Acid Esters in 
the Mud Snail (Ilyanassa obsoleta). Environmental health perspectives, 111, 426–430. 
https://doi.org/10.1289/ehp.5779 
Griffith, C. M., Baig, N., & Seiber, J. N. (2015). Contamination from Industrial Toxicants. I 
P. C. K. Cheung (Red.), Handbook of Food Chemistry (s. 1–27). Springer. 
https://doi.org/10.1007/978-3-642-41609-5_11-1 
Groot, A., Rosny, E., Juillan-Binard, C., Ferrer, J.-L., Laudet, V., Pierce, R., Pebay-Peyroula, 
E., Fontecilla-Camps, J., & Borel, F. (2006). Crystal Structure of a Novel Tetrameric 
Complex of Agonist-bound Ligand-binding Domain of Biomphalaria glabrata 
Retinoid X Receptor. Journal of molecular biology, 354, 841–853. 
https://doi.org/10.1016/j.jmb.2005.09.090 
 80 
Giulianelli, S., Primost, M. A., Lanari, C., & Bigatti, G. (2020). RXR Expression in Marine 
Gastropods with Different Sensitivity to Imposex Development. Scientific Reports, 
10(1), 9507. https://doi.org/10.1038/s41598-020-66402-1 
Hagger, J. A., Depledge, M. H., & Galloway, T. S. (2005). Toxicity of tributyltin in the 
marine mollusc Mytilus edulis. Marine Pollution Bulletin, 51(8–12), 811–816. 
https://doi.org/10.1016/j.marpolbul.2005.06.044 
Haschek, W. M., Rousseaux, C. G., & Wallig, M. A. (2010). Chapter 15—Immune System. I 
W. M. Haschek, C. G. Rousseaux, & M. A. Wallig (Red.), Fundamentals of 
Toxicologic Pathology (Second Edition) (s. 451–489). Academic Press. 
https://doi.org/10.1016/B978-0-12-370469-6.00015-5 
Haug, T., Falk-Petersen, S., Greenacre, M., Hop, H., Lindstrøm, U., Meier, S., Nilssen, K. T., 
& Wold, A. (2017). Trophic level and fatty acids in harp seals compared with common 
minke whales in the Barents Sea. Marine Biology Research, 13(9), 919–932. 
https://doi.org/10.1080/17451000.2017.1313988 
He, S., Li, P., & Li, Z.-H. (2021). Review on endocrine disrupting toxicity of triphenyltin from 
the perspective of species evolution: Aquatic, amphibious and mammalian. 
Chemosphere, 269, 128711. https://doi.org/10.1016/j.chemosphere.2020.128711 
Hiromori, Y., Aoki, A., Nishikawa, J., Nagase, H., & Nakanishi, T. (2015). Transactivation of 
the human retinoid X receptor by organotins: Use of site-directed mutagenesis to 
identify critical amino acid residues for organotin-induced transactivation. 
Metallomics: Integrated Biometal Science, 7(7), 1180–1188. 
https://doi.org/10.1039/c5mt00086f 
Ho, K. K. Y., Zhou, G.-J., Xu, E. G. B., Wang, X., & Leung, K. M. Y. (2016). Long-Term 
Spatio-Temporal Trends of Organotin Contaminations in the Marine Environment of 
Hong Kong. PLOS ONE, 11(5), e0155632. 
https://doi.org/10.1371/journal.pone.0155632 
Hoch, M. (2001). Organotin compounds in the environment—An overview. Applied 
Geochemistry, 16(7), 719–743. https://doi.org/10.1016/S0883-2927(00)00067-6 
Huang, W., Wu, Q., Xu, F., Li, L., Li, J., Que, H., & Zhang, G. (2020). Functional 
characterization of retinoid X receptor with an emphasis on the mediation of organotin 
poisoning in the Pacific oyster (Crassostrea gigas). Gene, 753, 144780. 
https://doi.org/10.1016/j.gene.2020.144780 
IJpenberg, A., Tan, N. S., Gelman, L., Kersten, S., Seydoux, J., Xu, J., Metzger, D., Canaple, 
L., Chambon, P., Wahli, W., & Desvergne, B. (2004). In vivo activation of PPAR 
target genes by RXR homodimers. The EMBO Journal, 23(10), 2083–2091. 
https://doi.org/10.1038/sj.emboj.7600209 
Jin, L., & Li, Y. (2010). Structural and functional insights into nuclear receptor signaling. 
Advanced drug delivery reviews, 62(13), 1218–1226. 
https://doi.org/10.1016/j.addr.2010.08.007 
Jones, B., Ohno, C., Allenby, G., Boffa, M., Levin, A., Grippo, J., & Petkovich, M. (1995). 
New retinoid-X-receptor subtypes in Zebra fish (Danio rerio) differentially modulate 
transcription and do not bind 9-cis retinoic acid. Molecular and cellular biology, 15, 
5226–5234. https://doi.org/10.1128/MCB.15.10.5226 
 81 
Jones, K. C., & de Voogt, P. (1999). Persistent organic pollutants (POPs): State of the 
science. Environmental Pollution, 100(1), 209–221. https://doi.org/10.1016/S0269-
7491(99)00098-6 
Kane, M. A. (2012). Analysis, occurrence, and function of 9-cis-retinoic acid. Biochimica et 
Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1821(1), 10–20. 
https://doi.org/10.1016/j.bbalip.2011.09.012 
Kojetin, D., Matta-Camacho, E., Hughes, T., Srinivasan, S., Nwachukwu, J., Cavett, V., 
Nowak, J., Chalmers, M., Marciano, D. P., Kamenecka, T., Shulman, A., Rance, M., 
Griffin, P., & Nettles, K. (2015). Structural mechanism for signal transduction in RXR 
nuclear receptor heterodimers. Nature communications, 6, 8013. 
https://doi.org/10.1038/ncomms9013 
Krezel, W., Dupé, V., Mark, M., Dierich, A., Kastner, P., & Chambon, P. (1996). RXR 
gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-
/RXR gamma -/- mutant mice are viable. Proceedings of the National Academy of 
Sciences of the United States of America, 93(17), 9010–9014. 
https://doi.org/10.1073/pnas.93.17.9010 
Lagarde, N., Delahaye, S., Zagury, J.-F., & Montes, M. (2016). Discriminating agonist and 
antagonist ligands of the nuclear receptors using 3D-pharmacophores. Journal of 
Cheminformatics, 8(1), 43. https://doi.org/10.1186/s13321-016-0154-2 
Lauretta, R., Sansone, A., Sansone, M., Romanelli, F., & Appetecchia, M. (2019). Endocrine 
Disrupting Chemicals: Effects on Endocrine Glands. Frontiers in Endocrinology, 10, 
178. https://doi.org/10.3389/fendo.2019.00178 
le Maire, A., Grimaldi, M., Roecklin, D., Dagnino, S., Vivat-Hannah, V., Balaguer, P., & 
Bourguet, W. (2009). Activation of RXR-PPAR heterodimers by organotin 
environmental endocrine disruptors. EMBO Reports, 10(4), 367–373. 
https://doi.org/10.1038/embor.2009.8 
Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., 
Speck, J., Kratzeisen, C., Rosenberger, M., & Lovey, A. (1992). 9-cis retinoic acid 
stereoisomer binds and activates the nuclear receptor RXR alpha. Nature, 355(6358), 
359–361. https://doi.org/10.1038/355359a0 
Link, J. S., Bogstad, B., Sparholt, H., & Lilly, G. R. (2009). Trophic role of Atlantic cod in 
the ecosystem. Fish and Fisheries, 10(1), 58–87. https://doi.org/10.1111/j.1467-
2979.2008.00295.x 
Madsen, A. K. (2016). Kloning, karakterisering og ligandaktivering av aryl 
hydrokarbonreseptor 2 (AHR2) fra Atlanterhavstorsk (Gadus morhua). 
https://bora.uib.no/bora-xmlui/handle/1956/11985 
Meyer, A., & Van de Peer, Y. (2005). From 2R to 3R: Evidence for a fish-specific genome 
duplication (FSGD). BioEssays: News and Reviews in Molecular, Cellular and 
Developmental Biology, 27(9), 937–945. https://doi.org/10.1002/bies.20293 
Miller, E. J., & Lappin, S. L. (2021). Physiology, Cellular Receptor. I StatPearls. StatPearls 
Publishing. http://www.ncbi.nlm.nih.gov/books/NBK554403/ 
Moraes, L. A., Swales, K. E., Wray, J. A., Damazo, A., Gibbins, J. M., Warner, T. D., & 
Bishop-Bailey, D. (2007). Nongenomic signaling of the retinoid X receptor through 
 82 
binding and inhibiting Gq in human platelets. Blood, 109(9), 3741–3744. 
https://doi.org/10.1182/blood-2006-05-022566 
Mortimer, D. N. (2013). 1 - Persistent organic pollutants in foods: Science, policy and 
regulation. I M. Rose & A. Fernandes (Red.), Persistent Organic Pollutants and Toxic 
Metals in Foods (s. 3–19). Woodhead Publishing. 
https://doi.org/10.1533/9780857098917.1.3 
Mukha, A., Kalkhoven, E., & van Mil, S. W. C. (2021). Splice variants of metabolic nuclear 
receptors: Relevance for metabolic disease and therapeutic targeting. Biochimica et 
Biophysica Acta (BBA) - Molecular Basis of Disease, 1867(10), 166183. 
https://doi.org/10.1016/j.bbadis.2021.166183 
Nakanishi, T., Nishikawa, J., Hiromori, Y., Yokoyama, H., Koyanagi, M., Takasuga, S., 
Ishizaki, J., Watanabe, M., Isa, S., Utoguchi, N., Itoh, N., Kohno, Y., Nishihara, T., & 
Tanaka, K. (2005). Trialkyltin Compounds Bind Retinoid X Receptor to Alter Human 
Placental Endocrine Functions. Molecular Endocrinology, 19(10), 2502–2516. 
https://doi.org/10.1210/me.2004-0397 
Palanisami, T., & Naidu, R. (2010). The Dirty Dozen Become the Dirty 21:the new list of 
stockholm priority contaminants(POPs). Remediation Australasia, 4, 2010. 
Pellizzato, F., Centanni, E., Marin, M. G., Moschino, V., & Pavoni, B. (2004). Concentrations 
of organotin compounds and imposex in the gastropod Hexaplex trunculus from the 
Lagoon of Venice. The Science of the Total Environment, 332(1–3), 89–100. 
https://doi.org/10.1016/j.scitotenv.2004.03.036 
Penvose, A., Keenan, J. L., Bray, D., Ramlall, V., & Siggers, T. (2019). Comprehensive study 
of nuclear receptor DNA binding provides a revised framework for understanding 
receptor specificity. Nature Communications, 10(1), 2514. 
https://doi.org/10.1038/s41467-019-10264-3 
Philip, S., Castro, L. F. C., da Fonseca, R. R., Reis-Henriques, M. A., Vasconcelos, V., 
Santos, M. M., & Antunes, A. (2012). Adaptive evolution of the Retinoid X receptor 
in vertebrates. Genomics, 99(2), 81–89. https://doi.org/10.1016/j.ygeno.2011.12.001 
Porter, B. A., Ortiz, M. A., Bratslavsky, G., & Kotula, L. (2019). Structure and Function of 
the Nuclear Receptor Superfamily and Current Targeted Therapies of Prostate Cancer. 
Cancers, 11(12), 1852. https://doi.org/10.3390/cancers11121852 
Rastinejad, F., Wagner, T., Zhao, Q., & Khorasanizadeh, S. (2000). Structure of the RXR–
RAR DNA-binding complex on the retinoic acid response element DR1. The EMBO 
Journal, 19(5), 1045–1054. https://doi.org/10.1093/emboj/19.5.1045 
Sandve, S. R., Rohlfs, R. V., & Hvidsten, T. R. (2018). Subfunctionalization versus 
neofunctionalization after whole-genome duplication. Nature Genetics, 50(7), 908–
909. https://doi.org/10.1038/s41588-018-0162-4 
Schøyen, M., Green, N. W., Hjermann, D. Ø., Tveiten, L., Beylich, B., Øxnevad, S., & Beyer, 
J. (2019). Levels and trends of tributyltin (TBT) and imposex in dogwhelk (Nucella 
lapillus) along the Norwegian coastline from 1991 to 2017. Marine Environmental 
Research, 144, 1–8. https://doi.org/10.1016/j.marenvres.2018.11.011 
Scott, G. R., & Sloman, K. A. (2004). The effects of environmental pollutants on complex 
fish behaviour: Integrating behavioural and physiological indicators of toxicity. 
Aquatic Toxicology, 68(4), 369–392. https://doi.org/10.1016/j.aquatox.2004.03.016 
 83 
Seo, Y.-W., Sanyal, S., Kim, H.-J., Won, D. H., An, J.-Y., Amano, T., Zavacki, A. M., Kwon, 
H.-B., Shi, Y.-B., Kim, W.-S., Kang, H., Moore, D. D., & Choi, H.-S. (2002). FOR, a 
Novel Orphan Nuclear Receptor Related to Farnesoid X Receptor*. Journal of 
Biological Chemistry, 277(20), 17836–17844. 
https://doi.org/10.1074/jbc.M111795200 
Sham, R. C., Ho, K. K. Y., Hui, T. T. Y., Zhou, G.-J., Chan, J. K. Y., & Leung, K. M. Y. 
(2021). Tissue distribution of triphenyltin compounds in marine teleost fishes. Journal 
of Hazardous Materials, 401, 123426. https://doi.org/10.1016/j.jhazmat.2020.123426 
Sladek, F. M. (2003). Nuclear receptors as drug targets: New developments in coregulators, 
orphan receptors and major therapeutic areas. Expert Opinion on Therapeutic Targets, 
7(5), 679–684. https://doi.org/10.1517/14728222.7.5.679 
Stokstad, E. (2021, april 7). Massive collapse of Atlantic cod didn’t leave evolutionary scars. 
Science | AAAS. https://www.sciencemag.org/news/2021/04/massive-collapse-
atlantic-cod-didn-t-leave-evolutionary-scars 
Szanto, A., Narkar, V., Shen, Q., Uray, I. P., Davies, P. J. A., & Nagy, L. (2004). Retinoid X 
receptors: X-ploring their (patho)physiological functions. Cell Death & 
Differentiation, 11(2), S126–S143. https://doi.org/10.1038/sj.cdd.4401533 
Søfteland, L., Holen, E., & Olsvik, P. A. (2010). Toxicological application of primary 
hepatocyte cell cultures of Atlantic cod (Gadus morhua)—Effects of BNF, PCDD and 
Cd. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 
151(4), 401–411. https://doi.org/10.1016/j.cbpc.2010.01.003 
Tate, B. F., Allenby, G., Janocha, R., Kazmer, S., Speck, J., Sturzenbecker, L. J., Abarzúa, P., 
Levin, A. A., & Grippo, J. F. (1994). Distinct binding determinants for 9-cis retinoic 
acid are located within AF-2 of retinoic acid receptor alpha. Molecular and Cellular 
Biology, 14(4), 2323–2330. 
Tokuç, A. (2013). Stockholm Convention (2001). I S. O. Idowu, N. Capaldi, L. Zu, & A. D. 
Gupta (Red.), Encyclopedia of Corporate Social Responsibility (s. 2329–2336). 
Springer. https://doi.org/10.1007/978-3-642-28036-8_15 
Tsuji, M., Shudo, K., & Kagechika, H. (2015). Docking simulations suggest that all-trans 
retinoic acid could bind to retinoid X receptors. Journal of Computer-Aided Molecular 
Design, 29(10), 975–988. https://doi.org/10.1007/s10822-015-9869-9 
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., 
Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., Olsson, I., Edlund, K., Lundberg, 
E., Navani, S., Szigyarto, C. A.-K., Odeberg, J., Djureinovic, D., Takanen, J. O., 
Hober, S., … Pontén, F. (2015). Proteomics. Tissue-based map of the human 
proteome. Science (New York, N.Y.), 347(6220), 1260419. 
https://doi.org/10.1126/science.1260419 
Ukaogo, P. O., Ewuzie, U., & Onwuka, C. V. (2020). 21 - Environmental pollution: Causes, 
effects, and the remedies. I P. Chowdhary, A. Raj, D. Verma, & Y. Akhter (Red.), 
Microorganisms for Sustainable Environment and Health (s. 419–429). Elsevier. 
https://doi.org/10.1016/B978-0-12-819001-2.00021-8 
Wang, K., Chen, S., Xie, W., & Wan, Y.-J. Y. (2008). Retinoids Induce Cytochrome P450 
3A4 through RXR/VDR-mediated Pathway. Biochemical pharmacology, 75(11), 
2204–2213. https://doi.org/10.1016/j.bcp.2008.02.030 
 84 
Waxman, J. S., & Yelon, D. (2007). Comparison of the expression patterns of newly 
identified zebrafish retinoic acid and retinoid X receptors. Developmental Dynamics, 
236(2), 587–595. https://doi.org/10.1002/dvdy.21049 
Weikum, E. R., Liu, X., & Ortlund, E. A. (2018). The nuclear receptor superfamily: A 
structural perspective. Protein Science, 27(11), 1876–1892. 
https://doi.org/10.1002/pro.3496 
Wennevik, V., Jørstad, K. E., Dahle, G., & Fevolden, S.-E. (2008). Mixed stock analysis and 
the power of different classes of molecular markers in discriminating coastal and 
oceanic Atlantic cod (Gadus morhua L.) on the Lofoten spawning grounds, Northern 
Norway. I J. Davenport, G. M. Burnell, T. Cross, M. Emmerson, R. McAllen, R. 
Ramsay, & E. Rogan (Red.), Challenges to Marine Ecosystems (s. 7–25). Springer 
Netherlands. https://doi.org/10.1007/978-1-4020-8808-7_1 
Wiens, M., Batel, R., Korzhev, M., & Müller, W. E. G. (2003). Retinoid X receptor and 
retinoic acid response in the marine sponge Suberites domuncula. The Journal of 
Experimental Biology, 206(Pt 18), 3261–3271. https://doi.org/10.1242/jeb.00541 
Windsor, F. M., Pereira, M. G., Morrissey, C. A., Tyler, C. R., & Ormerod, S. J. (2020). 
Environment and food web structure interact to alter the trophic magnification of 
persistent chemicals across river ecosystems. Science of The Total Environment, 717, 
137271. https://doi.org/10.1016/j.scitotenv.2020.137271 
Wolf, G. (2006). Is 9-Cis-Retinoic Acid the Endogenous Ligand for the Retinoic Acid-X 
Receptor? Nutrition Reviews, 64(12), 532–538. https://doi.org/10.1111/j.1753-
4887.2006.tb00186.x 
Yamada, M., Nagasaki, S. C., Suzuki, Y., Hirano, Y., & Imayoshi, I. (2020). Optimization of 
Light-Inducible Gal4/UAS Gene Expression System in Mammalian Cells. iScience, 
23(9), 101506. https://doi.org/10.1016/j.isci.2020.101506 
Yarsan, E., & Yipel, M. (2013). The Important Terms of Marine Pollution «Biomarkers and 
Biomonitoring,Bioaccumulation, Bioconcentration, Biomagnification». Journal of 
Molecular Biomarkers & Diagnosis, s1. https://doi.org/10.4172/2155-9929.S1-003 
Yuan, X., Lu, H., Zhao, A., Ding, Y., Min, Q., & Wang, R. (2020). Transcriptional regulation of 
CYP3A4 by nuclear receptors in human hepatocytes under hypoxia. Drug Metabolism 
Reviews, 52(2), 225–234. https://doi.org/10.1080/03602532.2020.1733004 
Zarifi, I., Kiparaki, M., Koumbanakis, K. A., Giagtzoglou, N., Zacharioudaki, E., Alexiadis, 
A., Livadaras, I., & Delidakis, C. (2012). Essential Roles of Da Transactivation 
Domains in Neurogenesis and in E(spl)-Mediated Repression. Molecular and Cellular 














Figure 28. Melting curve analysis. Melting curve produced by primer pairs for gmRXRa, gmRXRb1, gmRXRb2 
and gmRXRg. Relative fluorescence units (RFU) with respect to temperature us indicated as X-axis, and y-axis 
indicates temperature in Celsius.  
 
 
Figure 29. Tissue specific expression of gmRXRa. Figure shows the levels of detected gmRXRa transcripts 
correlating to tissue specific expression in Atlantic cod.   
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